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ABSTRACT 
he hypothalamus is a small, evolutionarily conserved brain region, necessary 
for our survival as individuals and as a species. It collects various sensory 
inputs, process them to maintain homeostasis and to overcome stressors, 
and generates outputs that affect the autonomic nervous system, the endocrine system 
and somatomotor behaviors. Energy metabolism, fluid balance, thermoregulation, 
sleep, aggression and reproduction are examples of functions under direct and indirect 
hypothalamic control. 
The neurochemical basis for these regulations involve different neurotransmitters and 
neuromodulators. The catecholamine dopamine is highly associated with various 
hypothalamic functions and behaviors, and has early on been shown to be present in 
intrinsic hypothalamic populations as well as incoming axon terminals. It acts on two 
types of receptors, excitatory D1-type and inhibitory D2-type, of which both have been 
reported to be expressed in the hypothalamus. 
To increase our understanding of these circuitries, this thesis aims to investigate the 
dopamine system in the hypothalamus, and the structures closely related to its inputs 
and outputs, namely the circumventricular organs and the pituitary.  
Immunohistochemical methods were used to generate a comprehensive distribution 
map of dopamine’s two main receptors, D1 and D2, and the neurochemical identity of 
these dopamine-receptor expressing cells were characterized. While the D2 receptor was 
widely expressed, D1 expression was found to be sparse. The suprachiasmatic nucleus, 
however, showed the contrary expression pattern. The D2 receptor could be localized to 
parvocellular neurons as well as endocrine cells of the pituitary. Little evidence for 
dopamine receptor expression on the magnocellular neurons could, however, be 
observed. Evidence for D1 receptor expression was also found in the subcommissural 
organ and a sub-cluster of ependymal cells in the third ventricle. 
Tuberoinfundibular dopamine (TIDA) neurons, which release dopamine in the portal 
vessels and thereby inhibit lactotrophs and prolactin release, were investigated in 
greater detail with regards to modulatory input, and morphological features. Anatomical 
substrate for innervation by serotonin and hypocretin/orexin on TIDA cell body and 
dendrites was identified together with electrophysiological evidence for excitation and 
suppression by hypocretin/orexin and serotonin or selective serotonin reuptake 
inhibitors, respectively. 
Morphological studies of male mice and rat TIDA neurons were done on tissue section 
and marker filled neurons by means of immunohistochemistry. TIDA neurons were 
T 
found to preferentially extend dendrites towards the third ventricle, possibly even into 
the ventricle. Axon terminals were found in the median eminence, but collateral 
branches oriented laterally could also be detected. An intermingling subcellular 
distribution of inhibitory and excitatory synapses, on somatic and dendritic level, was 
also identified. No significant differences could be observed in most morphological 
properties of mouse and rat TIDA neurons. However, rats exhibited a higher total 
number of TIDA neurons and a lower spine density than mice.  
Finally, the expression of three different calcium binding proteins, i.e. calbindin-D28k, 
calretinin and parvalbumin, were investigated within the arcuate nucleus. While both 
calbindin-D28k and calretinin could be detected in the arcuate nucleus, little evidence 
for parvalbumin expression was observed. None of the proteins were expressed in TIDA 
neurons or other investigated populations, except for proopiomelanocortin neurons that 
expressed both calbindin-D28k and calretinin. These neurons showed a rostrocaudal 
segregation of the two calcium binding proteins that resulted in two separate 
subpopulations. 
Overall, the studies presented in this thesis reveal a previously unappreciated 
abundance of dopaminergic involvement in the hypothalamic circuitries which will 
increase our understanding of mammalian homeostatic and endocrine control. 
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CHAPTER 1  
INTRODUCTION 
he human brain is a marvelous machinery that has been estimated to harbor 
more than 80 billion neurons and more or less equal number of other cell 
types. The earliest known record that mentions the human brain dates back 
to the 17th century B.C. Egypt, where the word “brain” written on papyrus in hieroglyphs 
(see Figure 1), was used to describe the symptoms, diagnosis, and prognosis of traumatic 
injuries of the head (Gross, 1987). Aristotle suggested the brain to be a cooling 
mechanism for the blood. Galen, however, concluded that it controls muscles and 
sensory processing. Although, not far from the truth, these conclusions were based on 
completely false assumptions of density differences between cerebrum and cerebellum. 
 
The modern view of the brain, where the neuron is seen as the functional unit, did not 
take shape until Camillo Golgi managed to stain neurons in the late 19th century (Golgi, 
1873), and thereby provided the foundation that could be used by Santiago Ramón y 
Cajal to formulate the neuron doctrine (De Carlos and Borrell, 2007). Since then, our 
understanding of the brain and how it “really” functions has increased exponentially. 
Yet remarkably numerous aspects of the brain, even at the most basic levels, remain 
unknown. In the same spirit as Golgi and Cajal, the studies included in this thesis, 
mainly focus on basic building blocks, i.e. neurons, neurotransmitters, neuromodulators 
and their receptors, in one of the evolutionarily oldest parts of the brain, the 
hypothalamus, and use anatomy and cytoarchitechtonics to explore functions and 
pathways and, thereby, to increase our understanding of this organ.  
T 
Figure 1. The hieroglyph for “brain” from 17th century B.C. 
ancient Egypt. Adapted from the work of Riccardo Metere as 
presented on Wikipedia. Licensed under the creative commons 
attribution-share alike 4.0 international license. 
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1.1 THE HYPOTHALAMUS 
The hypothalamus is a relatively small but evolutionarily old part of the brain, which, as 
the name suggests, is located just below the thalamus. In an adult human brain, it is 
roughly the size of a walnut and constitutes less than one percent of the total brain 
weight (see Saper and Lowell, 2014). Anatomically, the hypothalamus is divided into a 
number of scattered smaller nuclei, and thus presents an – at first glance – unstructured 
organization relative to many other brain regions. The two hemispheres of the 
hypothalamus are separated in the midline by the third ventricle (3V) and rostro-
caudally, it is usually subdivided into three parts. 
 
The rostral part, known as the preoptic area, is located dorsal to the optic chiasm and 
includes the different preoptic areas and nuclei and the suprachiasmatic nucleus. In the 
mid part, known as the tuberal hypothalamus, the pituitary stalk (a.k.a. the 
infundibulum) that connects the hypothalamus and the posterior pituitary, emerges 
from the ventral surface. The anterior and lateral hypothalamic areas but also the 
dorsomedial, ventromedial, paraventricular, supraoptic, and arcuate nuclei are included 
in this part. Finally, in the caudal aspect, the posterior hypothalamus contains the 
mammillary bodies nuclei and areas dorsal to them, like the posterior hypothalamic 
nuclei (see Saper, 2012). 
Despite its modest size, the hypothalamus is essential for the survival of the individual 
as well as the species as a whole, as it contains highly conserved neuronal circuitries that 
control basic functions. Energy metabolism, fluid balance, thermoregulation, sleep, 
aggression and reproduction are some examples of functions under direct and indirect 
hypothalamic control. The hypothalamus has an integrative role, where intero- and 
exteroceptive sensory inputs are collected and processed for activation of responses that 
maintain homeostasis and help the organism to overcome stressors and capitalize on 
opportunities for survival. These outputs are mediated through three major pathways: 
behavior through the somatomotor system, the autonomic nervous system and the 
endocrine system (see Swanson, 2000). 
Figure 2. Drawing of neurons, by Camillo Golgi. From "Sulla fina anatomia degli organi centrali del sistema 
nervoso", 1885. Original copy available at The Hagströmer Medico-Historical Library, Solna, Sweden. 
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1.1.1 Behavioral outputs from the hypothalamus 
As stimulation of different hypothalamic nuclei can rapidly result in fully formed 
somatomotoric behaviors, whilst lesion in the same area would inhibit the same 
behavior, it was initially thought that the hypothalamus contained different behavioral 
centers, e.g. for feeding (Anand and Brobeck, 1951a), drinking (Andersson et al., 1975) 
or attacking (Wasman and Flynn, 1962). This dual center hypothesis, as proposed by 
Eliot Stellar (1954), explained behavioral outputs from the hypothalamus as 
motivational states that direct the attention of an organism towards completing specific 
goals. Thus, early experiments identified e.g. the lateral hypothalamus as hunger center 
and ventromedial hypothalamus as a satiety center (Anand and Brobeck, 1951a, 1951b). 
Current thought suggests, however, that behaviors arise through an interplay of 
different brain regions and cannot be pinpointed to a discrete nucleus. The 
hypothalamus directs a certain behavior by increasing the likelihood to engage it (see 
Plata-Salamán, 1998), rather than activating a set of motor functions. Hunger and 
wakefulness can for instance increase the organism’s likelihood to eat, and more 
complex behaviors can be driven by e.g. sense of pleasure or disgust towards a certain 
odor or taste (see Saper and Lowell, 2014). 
Furthermore, different hypothalamic nuclei have been identified to be involved in a 
multitude of functions. For instance, in addition to promoting satiety, it was found that 
electrical stimulation of the ventromedial hypothalamus, in addition to its role in 
feeding, also could elicit aggression (Siegel and Skog, 1970; Kruk et al., 1979; also see 
Hashikawa et al., 2017), and more recent investigations have identified the ventral 
premammillary nucleus to be involved in both leptin mediated onset of puberty (Donato 
et al., 2011; Ratra and Elias, 2014) and intermale aggression (Stagkourakis et al., 
2018b).  
1.1.2 Autonomic outputs from the hypothalamus 
In the autonomic nervous system, preganglionic neurons of both sympathetic and 
parasympathetic pathways are directly and indirectly innervated by hypothalamic 
neurons located in the paraventricular nucleus, the lateral hypothalamic area and the 
arcuate nucleus (see Saper, 2002). Interestingly, endocrine glands in the periphery are 
also innervated, and hypothalamic neurons exert their regulation on e.g. insulin and 
glucagon by autonomic innervation of pancreas (Porte et al., 1975).  
1.1.3 Endocrine outputs from the hypothalamus 
The endocrine outputs of the hypothalamus are mainly subdivided into two routes. In 
the first route, magnocellular neurons (from Latin magnus, meaning “great” or “large”) 
that exhibit large cell bodies, are located in the supraoptic and paraventricular nuclei 
and extend axons through the pituitary stalk to the blood vessels in the posterior 
pituitary, where they secrete the hormones vasopressin (Vigneaud et al., 1953a) or 
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oxytocin (Vigneaud et al., 1953b) directly into the general circulation (see Flament-
Durand, 1980).  
In the second route, parvocellular neurons (from Latin parvus, meaning “small”), which 
exhibit smaller cell bodies than magnocellular neurons, extend axons that terminate on 
the first portal capillary blood vessels in the median eminence and release messenger 
molecules in the portal capillary system. These so called factors are subsequently 
transported to the second portal capillary bed in the anterior pituitary where they either 
excite or inhibit endocrine cells (see Flament-Durand, 1980). Parvocellular neurons are 
located in close proximity to the third ventricle from the preoptic area towards the 
infundibulum and can mainly be found in the medial preoptic area and the 
paraventricular, periventricular and arcuate nuclei. As magno- and parvocellular 
neurons secrete directly into the bloodstream, they are also known as neuroendocrine 
neurons. This thesis focuses particularly on the parvocellular system, which is further 
described in the section below. 
1.1.4 The parvocellular system 
The view of hypothalamus controlling the release of pituitary hormones has, not always 
been a dogma. In the 1930s it was generally believed that blood would flow from the 
pituitary to the hypothalamus, and that it was the pituitary that would control the 
hypothalamus (see Watts, 2011). The contemporary view of the parvocellular system 
could be established thanks to pioneering studies conducted by Geoffrey Harris (1948), 
who could demonstrate the correct blood flow direction with compelling evidence, and 
suggest hypothalamus as the controlling body, and subsequent identification of 
Figure 3. Schematic presentation of parvocellular neurons. Parvocellular neurons of the hypothalamus 
terminate in the median eminence, where they secrete factors into first capillary blood vessels. These factors 
are transported by the blood to the anterior pituitary and either excite (+) or inhibit (-) endocrine cells that 
release hormones into the systemic blood. See list for abbreviations. 
GHRH SST
GH TSH PRL LH/FSH ACTH
TRH DA GnRH CRH
Somatotrophs
Hypothalamus
Anterior Pituitary
ME
Blood
LactotrophsThyrotrophs Gonadotrophs Corticotrophs
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releasing factors in 1968 by Roger Guillemin (Burgus et al., 1969) and Andrew V. Schally 
(Bøler et al., 1969). 
The parvocellular system includes five axes defined by their target endocrine cell in the 
pituitary. These are the thyro-, cortico-, gonado-, somato-, and lactotrophic axes. Each 
axis is mainly associated with a distinct cell population in the hypothalamus with specific 
releasing and inhibiting factors, although cross-talk has been suggested to occur. For 
example, in addition to its powerful effects on the thyrotrophic axis, thyrotropin-
releasing hormone also stimulate the release of prolactin in the lactotrophic axis 
(Bowers et al., 1971; Lamberts and Macleod, 1990). The lactotrophic axis, which is the 
main circuitry controlling the secretion of prolactin, has been investigated in several of 
the studies in this thesis and will be discussed further in the following section. 
1.1.5 The lactotrophic axis 
In the lactotrophic axis, the release of the polypeptide hormone prolactin, is controlled. 
Prolactin, which was first discovered in animals (Stricker and Grueter, 1928; Riddle et 
al., 1933), and much later confirmed to exist in humans (Friesen et al., 1970), is best 
known for initiating lactation in female mammals (see Freeman et al., 2000; also see 
Grattan, 2015). Investigations have however identified prolactin as a pleotropic 
hormone that is involved in several hundreds of different process, in both humans and 
other vertebrates, e.g. stimulation of paternal behavior in birds (Buntin et al., 1991) or 
promotion of gonadal activity (Rubin et al., 1976; Buntin and Tesch, 1985; Gunasekar 
et al., 1988). Its receptor is widely expressed throughout the body of both sexes, and it 
is difficult to find a tissue that does not express prolactin receptor (see Bole-Feysot et al., 
1998). 
Many early interrogations of the lactotrophic axis failed to identify a “prolactin releasing 
factor” similar to what is found in the other parvocellular axes. These initial failures 
turned out to be due to two reasons. First, lactotrophs are primarily controlled by 
inhibition, rather than stimulation. This is illustrated in pituitary stalk transection 
experiments causing a general drop in serum pituitary hormone levels, with the 
exception of prolactin, which rises (Gust et al., 1987), and in the anterior pituitary grafts 
transplantations under the kidney capsule, which results in an increase of prolactin, but 
not other pituitary hormones (Everett, 1954; Nikitovitch-Winer and Everett, 1958, 
1959). 
Second, the lactotrophic axis utilizes a biogenic amine rather than a neuropeptide as a 
hypothalamic inhibiting factor. Thus, it was found that parvocellular tuberoinfundibular 
dopamine (TIDA) neurons, located in the hypothalamic arcuate nucleus (Fuxe, 1964; 
Hökfelt, 1967; Björklund et al., 1973), provide inhibition by releasing dopamine into the 
portal vessels. Released dopamine is, as described previously, transported to the 
anterior pituitary where it acts on inhibitory D2-type receptors on the lactotrophs 
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(compare section 1.2.3), to inhibit Ca2+-dependent exocytosis of prolactin (see Ben-
Jonathan and Hnasko, 2001). 
Dopamine-mediated inhibition on lactotrophs results in a powerful suppression of 
prolactin release, so that lactation only occurs in nursing females. The strength of this 
dopamine inhibition is illustrated by the potency of dopamine agonists in the treatment 
of hyperprolactinemia and prolactinomas (Molitch et al., 1985) which also lead to 
common sexual side effects like reduced libido and menstrual cycle abnormalities 
(Ghadirian et al., 1982) or less common side effects like galactorrhea, in antipsychotic 
drug treatments with dopamine antagonists (Polishuk and Kulcsar, 1956; Clemens et 
al., 1974).  
1.1.6 Tuberoinfundibular dopamine neurons 
More than half a century ago, TIDA neurons were first identified with Falck-Hillarp 
visualization (see section 1.2.2), and were subsequently investigated by their 
immunoreactivity for tyrosine hydroxylase (TH, see section 1.2.1), and their 
morphological features (Chan-Palay et al., 1984; van den Pol et al., 1984) and projection 
to the median eminence was described (Lichtensteiger and Langemann, 1965; Fuxe and 
Hökfelt, 1966; Björklund et al., 1970, 1973). 
More recent ex vivo studies, first by Lyons et al. (2010), on the electrophysiological 
cellular and network properties of TIDA neurons have revealed a peculiar membrane 
potential oscillation (see also e.g. Brown et al., 2012; Yang et al., 2012; Romanò et al., 
2013; Zhang and van den Pol, 2015; Stagkourakis et al., 2018a), where the cells 
rhythmically alternate between periods of quiescence (DOWN state) and phasic (UP 
state) firing (see Figure 4). In rats, these states are synchronized through a mechanism 
involving gap junctions, which provide a strong electrical coupling between TIDA 
neurons (Stagkourakis et al., 2018a); mouse TIDA neurons, on the other hand, are not 
synchronized and show complete lack of gap junctions. 
 
Since prolactin has been found to provide feedback and exert direct effects on TIDA 
neurons (Lyons et al., 2012), it is likely that the central regulation of serum prolactin 
Figure 4. Electrophysiological properties of rat TIDA neurons. Current clamp whole-cell recording of a 
TIDA neuron from a juvenile male rat show a rhythmic oscillation that alternates between up () and down 
() states.  


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resides within the TIDA neurons themselves, which makes these cells particularly 
interesting to study in conditions where the systemic prolactin level is altered. Sexual 
side effects, including amenorrhea, infertility, anorgasmia, impotence, and impaired 
libido, are common in patients under antidepressant selective serotonin reuptake 
inhibitor (SSRI) treatments (Clayton et al., 2002) and are likely caused by systematic 
elevation of prolactin (Safarinejad, 2008; Madhusoodanan et al., 2010). As such, the 
effects of serotonin and SSRIs on TIDA neurons were investigated in study III. 
Prolactin secretion is also variable over the day, with plasma levels in rats (Clark and 
Baker, 1964; Dunn et al., 1980), as well as humans (Nokin et al., 1972; Sassin et al., 
1972) increasing during sleep. Based on these observations, the effects of two molecules 
that regulate the sleep-wake cycles, i.e. the wakefulness promoting hypothalamic 
peptide, hypocretin/orexin (see de Lecea et al., 1998; Sakurai et al., 1998; Martin-
Fardon et al., 2018), and the sleep-regulating pineal hormone, melatonin (Johnston and 
Skene, 2015), were investigated in study IV. 
In addition to the modulators mentioned above, several other messenger molecules have 
been identified in other studies (e.g. Lyons et al., 2010; Briffaud et al., 2015; 
Stagkourakis et al., 2016) to affect TIDA electrophysiology. These findings together raise 
a number of questions regarding the morphological and neurochemical properties of 
these cells, which have been addressed by histochemical techniques in the second study 
of this thesis. 
1.2 DOPAMINE AND DOPAMINE RECEPTORS 
Dihydroxyphenethylamine, more commonly known as dopamine, is an organic 
compound belonging to the catecholamine family. It was first synthesized in 1910 
(according to Hornykiewicz, 2002) and identified in the human brain as a precursor to 
noradrenaline in the 1950s (Carlsson et al., 1957, 1958; Montagu, 1957). Subsequently, 
in 1958, Arvid Carlsson and Nils-Åke Hillarp identified it to act as a neurotransmitter in 
its own right (see Björklund and Dunnett, 2007); a discovery that resulted in the 2000 
Nobel Prize in Physiology and Medicine being awarded to Dr. Carlsson. 
Additionally, dopamine has also been found to be an active compound in many plants, 
where the fruit pulp of bananas contain the highest concentrations observed (Kulma and 
Szopa, 2007). The underlying neuronal circuitries involving dopamine actions in 
bananas have, however, not been established yet. Contrary to its precursor L-3,4-
dihydroxyphenylalanine (L-DOPA, a.k.a. levodopa), dopamine cannot cross the blood-
brain barrier, and therefore cannot act on the brain when consumed orally (Bertler et 
al., 1966). 
1.2.1 Catecholamine biosynthesis 
In the brain, dopamine is mainly synthesized from L-DOPA by the enzyme DOPA 
decarboxylase (DDC; a.k.a. aromatic amino acid decarboxylase, AADC). L-DOPA is 
 8 
converted from the non-essential amino acid L-tyrosine by the enzyme tyrosine 
hydroxylase (see Figure 5). Dopamine by itself is a precursor to other catecholamines 
(see Figure 6), as it can be converted to the neurotransmitter norepinephrine (a.k.a. 
noradrenaline) by presence of the enzyme dopamine β-hydroxylase, which can be 
further processed by the enzyme phenylethanolamine N-methyltransferase (a.k.a. 
phenylalanine hydroxylase) to form epinephrine, a.k.a. adrenalin (see Daubner et al., 
2011). 
 
Tyrosine hydroxylase, is the rate limiting enzyme of the biosynthesis of these 
catecholamines (Nagatsu et al., 1964). It has four different serine residues, and the 
enzyme activity can be regulated through phosphorylation and dephosphorylation of 
these serine sites by kinases and phosphatases (see Daubner et al., 2011). The enzyme 
is further regulated by a phosphorylation dependent feedback mechanism, where the 
catecholamines themselves (Daubner et al., 1992) can compete with the cofactor 
tetrahydrobiopterin and inhibit the enzyme activity. 
 
1.2.2 Dopamine expression in the brain 
In the early 1960s, Bengt Falck and Nils-Åke Hillarp introduced a method that enabled 
fluorescence detection of catecholamines (Falck, 1962; Falck and Torp, 1962; Falck et 
al., 1982). This Falck-Hillarp visualization technique was used by Annica Dahlström and 
Kjell Fuxe (Dahlström and Fuxe, 1964) to present the first mapping of catecholamine 
expressing neurons in the brain. As these cell populations did not always adhere to 
classical neuroanatomical boundaries, an alphanumerical classification of the 
catecholamine expressing neurons was introduced. Thus, dopamine and 
norepinephrine expressing neurons were categorized in the A-groups, and serotonin 
Figure 5. Dopamine biosynthesis. Dopamine is synthesized from L-tyrosine in two enzymatically catalyzed 
steps. The first reaction, where tyrosine hydroxylase catalyzes the production of L-DOPA is the rate limiting 
step. BH4, tetrahydrobiopterin; BH2, dihydrobiopterin; TH, tyrosine hydroxylase; L-DOPA, L-3,4-
dihydroxyphenylalanine; DDC, DOPA decarboxylase. 
Figure 6. Norepinephrine and epinephrine biosynthesis. Cells that lack DBH cannot produce 
norepinephrine or epinephrine as these molecules are synthesized from dopamine. Vit C, vitamin C; DHA, 
dehydroascorbic acid; SAM, S-adenosyl methionine HCY, homocysteine; DBH, dopamine β-hydroxylase; 
PNMT, phenylethanolamine N-methyltransferase. 
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and adrenaline expressing neurons were categorized in B- and C-groups respectively 
and numbered sequentially according to their rostro-caudal distribution from medulla 
oblongata to the diencephalon. 
The initial mapping was, however, mostly focused on the midbrain, and did not cover 
the entire hypothalamus. The remaining dopamine producing neurons in the brain were 
later described by their immunoreactivity for tyrosine hydroxylase (Pickel et al., 1975; 
Hökfelt et al., 1976; Chan-Palay et al., 1984; van den Pol et al., 1984) and their axonal 
projections were investigated subsequently with the retrograde tracer horseradish 
peroxidase (Ljungdahl et al., 1975). 
There are three different midbrain dopamine cell populations: the cells in the 
retrorubral field (A8), the cells in the substantia nigra (A9) and the cells in the ventral 
tegmental area (A10). These cells have undergone substantial anatomical (e.g. German 
and Manaye, 1993) and physiological investigations and found to play vital roles in the 
regulation of voluntary movement (Iversen and Koob, 1977), emotion (Nestler and 
Carlezon, 2006) and reward (see Tzschentke and Schmidt, 2000). For instance, loss of 
dopamine neurons in the substantia nigra pars compacta is the main pathological 
characteristic of Parkinson’s disease (see e.g. Björklund and Dunnett, 2007; Lees et al., 
2009; Sveinbjornsdottir, 2016). 
In the hypothalamus, there are five major dopaminergic cell populations (A11-A15), 
where the parvocellular neuroendocrine TIDA neurons (compare 1.1.6) belong to the 
A12 group. It should be emphasized that not all hypothalamic tyrosine hydroxylase 
expressing neurons are dopaminergic, as immunohistochemical investigations of the 
ventral A12 cells in the arcuate nucleus for instance, has revealed a lack of the enzyme 
AADC (Meister et al., 1988). Another dopaminergic cell group can also be found in the 
olfactory bulb (A16). 
1.2.3 Dopamine receptors 
Dopamine acts on two major types of G-protein coupled receptors: the excitatory D1-
like, constituting of the D1 and D5 subtypes, and the inhibitory D2-like, constituting of 
D2, D3 and D4 subtypes (Spano et al., 1978; Kebabian and Calne, 1979). The D2 
receptor has also been identified to exist in two different isoforms; a long (D2L) that is 
most abundant in the brain, and a short (D2S) that is predominant in the brainstem 
(Montmayeur et al., 1991). Dopamine receptors exert their effect on the cell by either 
increasing (D1-like) or decreasing (D2-like) the formation of the second messenger 
cyclic adenosine monophosphate (cAMP) through adenylyl cyclase mediated 
mechanisms. 
Dopamine receptors are expressed throughout the brain, with the D1 and the D2 
subtypes being the most abundant, and both these receptors have been identified to be 
expressed within the hypothalamus (Mansour et al., 1990). Although, most studied for 
their involvement in the mesolimbic (e.g. Sawaguchi and Goldman-Rakic, 1991; Tran et 
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al., 2005) and nigrostriatal pathways (see Korchounov et al., 2010), dopamine receptors 
have been identified in a variety of hypothalamically mediated functions and behaviors. 
These include for instance food intake (Parada et al., 1988; Caulliez et al., 1996; Chen et 
al., 2014; Mirmohammadsadeghi et al., 2018), circadian rhythm (Yamada and Martin-
Iverson, 1991; Viswanathan et al., 1994; Duffield et al., 1998), pituitary hormone 
secretion (Bluet-Pajot et al., 1990; Crowley et al., 1991; Borowsky and Kuhn, 1992), as 
well as defensive (Filibeck et al., 1988) and reproductive (Fabre-Nys et al., 2003) 
behaviors. The broad role of dopamine in the hypothalamus is further illustrated by the 
observed side effects like tachycardia and hypotension in patients undergoing dopamine 
agonist based treatments (Rosell et al., 2015). 
 
These studies suggest a broader role for dopamine in homeostatic and endocrine 
functions in the hypothalamus and implies the existence of several other dopamine 
dependent circuitries in addition to the lactotrophic axis. The dopaminergic influences 
in the hypothalamus can be explained by the distribution of its receptor among different 
hypothalamic cell populations. Yet, the expression of these two receptors in the 
hypothalamus has previously not been investigated in greater detail. Two of the studies 
included in this thesis (studies V and VI), address this lack of information and provide a 
thorough map of cells expressing D1 or D2 receptors within the hypothalamus and the 
structures that are closely related to it; namely the pituitary and the circumventricular 
organs. 
1.3 CALCIUM BINDING PROTEINS 
In addition to TIDA neurons that have been discussed in the previous sections and 
studied in this thesis, several other neuronal populations occupy the arcuate nucleus. 
This includes for instance agouti-related protein/neuropeptide tyrosine (AgRP/NPY) 
and proopiomelanocortin/cocaine- and amphetamine-regulated transcript 
(POMC/CART) -expressing neurons involved in metabolic regulation (Broberger et al., 
Figure 7. Dopamine actions are mediated through two types of G-protein coupled receptors. When 
dopamine binds to one of its receptors, it induces a conformational change that allows the receptor to act 
with G-proteins to either activate (D1) or inhibit (D2) adenylyl cyclase, which catalyzes the creation of the 
second messenger cAMP. ATP, adenosine triphosphate; cAMP, cyclic adenosine monophosphate. 
Dopamine
D1R
ATP
D2R
adenylyl cyclase
post-synaptic neuron
Gs Gi
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1998), somatostatin (SST) and growth hormone-releasing hormone (GHRH) expressing 
neurons involved in the somatotrophic axis and kisspeptin (KSP) expressing neurons 
involved in the gonadotrophic axis (see Jameson and Harrison, 2013 p.17). As these 
neurons are involved in distinct hypothalamic circuitries and exhibit different 
neurochemical, physiological (e.g. Spanswick et al., 1997; Cowley et al., 2001, 2003; 
Ohkura et al., 2009) and morphological properties, knowledge about these cells’ 
molecular repertoires and the differences among them can provide valuable insight on 
how several properties of the cells, e.g. the membrane properties are regulated.  
The neuronal signal transduction machinery relies on an action potential mediated 
calcium rise, and utilizes several proteins that allow vesicles to fuse to the membrane 
and release neurotransmitters (see Brini et al., 2014). Calcium, which acts as a second 
messenger, binds to one of the key components, synaptotagmin-1, and induces the 
neurotransmitter release (Geppert et al., 1994); a discovery for which Thomas C Südhof 
shared the Nobel Prize in Physiology or Medicine in 2013. Consequently, the 
intracellular calcium levels in neurons are tightly regulated by various kinds of calcium 
pumps/channels and binding proteins (see Kramer, 2016). Although these calcium 
binding proteins have been classified as either sensors, which facilitate signal 
transduction, or buffers, which maintain a stable calcium level in the cytosol (Dalgarno 
et al., 1984; Heizmann, 1993; Burgoyne, 2007), it is becoming apparent that several of 
these proteins are involved in both functions, and pure calcium buffers are less common 
(Schwaller, 2009).  
In the mammalian brain, several different calcium binding proteins are expressed and 
they have been used as a histochemical tool to identify and classify different neuronal 
populations (Baimbridge et al., 1992). Three different calcium binding proteins, 
belonging to the “EF-hand” family (Moncrief et al., 1990; Lee et al., 1991; Nakayama et 
al., 1992), namely calbindin D-28k (Taylor and Wasserman, 1967; Jande et al., 1981; 
also see Schmidt, 2012), calretinin (Rogers, 1987; see Schwaller, 2014) and 
parvalbumin (Henrotte, 1952; Celio and Heizmann, 1981) have been used in the first 
study of this thesis to investigate different neuronal populations in the arcuate nucleus. 
Of these three proteins, parvalbumin is the only that has not been identified to have 
additional calcium sensor functions, and is possibly the only pure calcium buffer 
(Schwaller, 2009). 
1.4 THE PITUITARY 
The pituitary gland, classically known as the hypophysis, is usually referred to as the 
master endocrine organ and is present, albeit with some structural variabilities, in all 
vertebrates. In humans it is roughly about the size of a pea and weighs about 0.5 grams. 
It is positioned ventral to the hypothalamus and is directly connected to the brain 
through the pituitary stalk. The pituitary is divided into two main lobes, the anterior and 
the posterior. In some species like mice, rats and fish in general, a third intermediate 
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lobe located in-between the anterior and the posterior lobe, is also present. This lobe is 
absent in birds and rudimentary in humans (see e.g. Melmed, 2011). To examine the 
possible role of dopamine in the pituitary, the expression of the D1 and D2 receptors has 
been investigated in study IV and V included in this thesis. 
1.4.1 The anterior pituitary 
The anterior pituitary, also known as adenohypophysis, is the glandular part of the 
pituitary and harbors several different types of endocrine cells (see Strand, 1999) that 
are regulated centrally by neurotrophic factors originating from parvocellular 
neuroendocrine neurons of the hypothalamus (see section 1.1.4). 
1.4.2 The intermediate lobe 
In mice and rats, and to some degree in humans, although less developed and often 
considered part of the anterior pituitary, the intermediate lobe mostly constitutes of 
melanotrophs, which process the precursor molecule POMC, and releases α-melanocyte 
stimulating hormone (α-MSH) and β-endorphin (Mains and Eipper, 1979; Jackson and 
Lowry, 1983; Chang and Loh, 1984). This processing is different than what is found in 
the anterior lobe where the main released hormones are adrenocorticotrophic hormone 
(ACTH) and β-endorphin (Strand, 1999).  
The melanotrophs of the intermediate lobe are directly innervated by a subpopulation 
of A14 dopamine neurons located in the periventricular nucleus of the hypothalamus 
(Goudreau et al., 1992, 1995; Demaria et al., 2000). It should, however, be mentioned 
that a review of older literature reveals some ambiguity about the nomenclature and 
anatomical location of these neurons (Björklund et al., 1973; also see Saland, 2001).  
In amphibians, reptiles and fishes (Hogben and Slome, 1931; Kawauchi et al., 1983), 
α-MSH is involved in pigmentation of the skin. Although the exact function of the 
intermediate lobe melanotrophs in humans has not been fully elucidated, α-MSH has 
been suggested to be involved in pigmentation (Krude et al., 2003) as well as in pivotal 
control of the hypothalamic-pituitary axes (see Saland, 2001). 
1.4.3 The posterior pituitary 
The posterior pituitary (see Flament-Durand, 1980), classically known as 
neurohypophysis, does not synthesize any hormones by itself, but mainly contains axon 
terminals from magnocellular neuroendocrine neurons, which release the hormones 
oxytocin and vasopressin directly into the bloodstream (see section 1.1.3). 
1.5 CIRCUMVENTRICULAR ORGANS 
In 1958, the term “circumventricular organs” was proposed by the Austrian anatomist 
Helmut Hofer to describe the structures around the ventricular system of the brain 
(Hofer, 1958). Circumventricular organs are in contact with both the blood and the 
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cerebrospinal fluid and are not restricted by the blood brain barrier, thus constituting 
an interface between the brain and the rest of the body (see Gross, 1992).  
Circumventricular organs can be either sensory, and provide a windows through which 
the endocrine or autonomic nervous system receives systemic feedback, or secretory, 
and act as a site of hormonal release. While median eminence, the neurohypophysis, the 
intermediate lobe of the pituitary gland, the pineal gland and the subcommisural organ 
are considered to belong to secretory, the subfornical organ, the organum vasculosum 
of the lamina terminalis and area postrema are considered to belong to sensory 
circumventricular organs (see Fry and Ferguson, 2007). 
Circumventricular organs are partly composed by ependymal cells, a type of neuroglia, 
which line the ventricle walls. A specific type of ependymal cells, known as tanycytes, are 
found in the third ventricle. These cells exhibit long processes extending into the arcuate 
nucleus and have recently been identified to gate leptin into the brain (Balland et al., 
2014). The close proximity to, and direct interaction with, the hypothalamus makes 
circumventricular organs an integral part of hypothalamic circuitries. 
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CHAPTER 2  
MAIN OBJECTIVES 
ased on the surge of new discoveries on different cellular, physiological and 
network properties of hypothalamic neurons, and the lack of fundamental 
understanding for the molecular basis of these discoveries, this thesis aims to 
investigate the dopamine system in the hypothalamus, the pituitary and the 
circumventricular organs, from a molecular and histochemical perspective, with specific 
focus on dopamine D1 and D2 receptors and the tuberoinfundibular dopamine (TIDA) 
neurons, in the arcuate nucleus.  
The specific aims were to: 
 define the expression pattern of three major calcium-binding proteins, namely 
calbindin-D28k, calretinin and parvalbumin, in the arcuate nucleus (study I) 
 describe the morphological features of TIDA neurons in male rodents and identify 
potential species differences (study II) 
 determine the serotonergic innervation pattern of TIDA neurons (study III) 
 determine the hypocretin-/orexinergic innervation pattern of TIDA neurons (study 
IV) 
 provide a comprehensive distribution map and neurochemical characterization of 
D1 (study VI) and D2 (study V) receptor expressing cells in the hypothalamus, the 
pituitary and certain circumventricular organs 
B 
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CHAPTER 3  
ASPECTS OF METHODOLOGY 
etailed descriptions of materials and methods used in the studies included in 
this thesis have been presented in the corresponding section of each paper 
(see studies I-VI). The following sections provide an overview of these 
methods and consider the specific choice, and their strengths and limitations. 
3.1 ANIMAL MODELS 
These studies aim to investigate the hypothalamic dopamine system in the mammalian 
brain. Mice and rats are two extensively studied models that have been frequently used 
in research and have a well characterized brain anatomy (Paxinos and Franklin, 2001; 
Paxinos and Watson, 2007). As the hypothalamus also is evolutionally well preserved 
compared to other brain regions and exhibit conserved anatomy across vertebrates (see 
Xie and Dorsky, 2017), these two species constitute good models for the aims of our 
investigations. Additionally, the relatively short gestation time is beneficial when 
studying animals through the life cycle and when breeding is required (e.g. in genetically 
modified animals; see below). 
It should be noted that early on, Baker et al. (1983) could identify variations in number 
of dopamine neurons in the hypothalamus of two different mouse strains (BALB/c and 
CBA). The functional implications of this difference remains, however, unknown. As our 
aim is to investigate the dopamine systems in the hypothalamus, rather than quantify 
strain differences, we have adhered, throughout our studies, to a single strain from each 
species; i.e. C57BL/6 for mice and Sprague Dawley (SD) for rats.  
For obvious reasons, explainable by the nature of each study, several different transgenic 
mouse lines (see following sections below) had to be used. These strains are all derived 
from C57BL/6 mice. For rats, on the other hand, only wild type animals were used. The 
somehow restricted repertoire of animal strains provide a reduction of unwanted 
variables across studies, which makes it easier to understand the dopaminergic system 
in the hypothalamus, and is highly desirable at this level of basic interrogation. This 
reduced biological diversity might, however, overlook important factors that could have 
D 
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crucial impact in for instance drug development. Future studies should therefore further 
investigate to what extend these data can actually be extrapolated to either other strains 
or species (e.g. humans). 
3.1.1 Transgenic reporter animals 
Certain receptors and membrane proteins can be expressed at lower levels compared to 
other cell proteins, such as neuropeptides, that are constantly secreted. The mRNA 
expression level can also vary greatly among different cell populations (compare Paper 
V). These features make it challenging to identify, map and characterize these cells only 
by the means of in situ hybridization (ISH) techniques. As neurotransmitter and 
neuropeptide receptors are mainly localized at the synapse on the cell membrane, they 
are also difficult to target with conventional immunohistochemistry (IHC) techniques 
with a satisfactory resolution (also compare sections 3.3 and 3.4). It is therefore not 
possible to reach the aims of this thesis exclusively by means of ISH and/or IHC 
techniques on wild type animals, and it is so necessary to use bioengineered tools.  
Transgenic animals (Jaenisch and Mintz, 1974) expressing a reporter gene under the 
control of a certain promoter, i.e. a receptor promoter, provide a good opportunity to 
identify those cells that specifically express the protein of interest (see Spergel et al., 
2001). Using transgenic animals for this purpose is, however, not a straightforward 
procedure as there is a risk for both false positive (i.e. cells that express the reporter but 
not the receptor gene) caused by the influence of endogenous upstream promoters (see 
Conlon, 2011), and false negative expression (i.e. cells that express the receptor but not 
the reporter gene; compare A15 dopamine cells in study V). Furthermore, the random 
integration of the insert into the genome may affect the neighboring genes or interrupt 
the function of endogenous genes (see Babinet et al., 1989), which could lead to 
undesirable changes in phenotype. To minimize the negative side effects of such event, 
hemizygous animals, that carry the transgene only in one chromosome, are used. As the 
transcriptional profile of different neuronal populations are variable, correct expression 
in one brain region does not necessarily extrapolate to other brain regions, and to be 
able to draw valid conclusions, the expression of the reporter gene must be properly 
validated. 
3.1.2 Drd1/Drd2-EGFP BAC transgenic mice 
To investigate the distribution of D1 and D2 receptor expressing cells in the 
hypothalamus, circumventricular organs and the pituitary gland, two transgenic mouse 
lines expressing enhanced green fluorescence protein (EGFP) under either Drd1 or 
Drd2 promoter, within a bacterial artificial chromosome (BAC), were used. Both of these 
lines were developed by the Gene Expression Nervous System Atlas (GENSAT; 
www.gensat.org) program at Rockefeller University (Gong et al., 2003) and maintained 
in our own breeding facility. These transgenic animals will be referred to as Drd1- and 
Drd2-EGFP mice. 
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A BAC has the ability to carry a DNA fragment of several hundred kilobases and can thus 
be used to insert a large portion of a gene’s promoter and upstream regulatory elements 
into a transgene (see Heintz, 2001). Thus, it is possible to rapidly create transgenic 
animals without any a priori knowledge of the exact fragment and function of the 
regulatory elements. This lack of information is not completely unproblematic as the 
insert could carry regulatory elements that affect gene expression independently of the 
transgene itself and lead to altered cellular phenotype. Such issues have been reported 
by Kramer et al. (2011), who observed altered physiology and behavior in the Swiss 
Webster (SW) Drd2-EGFP BAC transgenic mice. Later studies suggested, however, that 
these abnormal phenotypes were likely raised, because that specific transgene, was 
backcrossed on the outbred SW strain and were homozygous for the Drd2-EGFP BAC 
(Chan et al., 2012). The same study could not identify any abnormalities in the inbred 
C57BL/6 hemizygous transgene. 
It should be noted that both Drd1- and Drd2-EGFP transgenic mice used in the studies 
included in this thesis have been backcrossed for at least three generations in the inbred 
C57BL/6 mouse before use. These strains have been maintained for almost a decade and 
no abnormal behaviors have been observed. The behavior and neurochemical 
phenotype of both strains have also been validated in the basal ganglia in other studies 
(Bonito-Oliva et al., 2016), and in current studies included in this thesis, the strains have 
been further validated by the means of multiplex ISH. These transgenic animals have 
thereby undergone the extensive characterization that is the prerequisite for obtaining 
reliable data with transgenic animals. It should however be noted that this obtained 
confidence in these two strains, cannot automatically be extrapolated to other 
transgenes. 
3.1.3 DAT-tdTomato knock-in mice 
To identify neurons expressing the dopamine transporter (DAT) in the arcuate nucleus, 
DAT-cre knock-in mice were crossed with a tdTomato floxed reporter mice to create the 
DAT-tdTomato strain. Contrary to the strains used to identify dopamine receptors, the 
DAT-cre strain was generated with a knock-in strategy with a fully identified insert 
(Zhuang et al., 2005), an therefore does not present concerns with regulatory elements 
as it is the case with BAC transgenic animals. 
As this strain was not used for a mapping study, but only to identify a discrete cell 
population, a full validation and characterization of the transgene was not considered 
necessary. Nevertheless, it should be noted that the specific strain has been validated in 
other studies and extensively used to identify non-hypothalamic dopaminergic cells 
(Zhuang et al., 2005; Ekstrand et al., 2007; Turiault et al., 2007) as well as TIDA neurons 
(Stagkourakis et al., 2018a). 
Following the reporter expression validation in the arcuate nucleus, these animals also 
made it possible to visualize and directly identify TIDA neurons in electrophysiological 
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experiments by fluorescence, which tremendously increased the success rate of the 
experiments, and enabled much faster data collection (see study II). 
3.1.4 EGFP and tdTomato reporters 
Together with transgenic animals, two different reporter proteins, namely EGFP and 
tdTomato, have been used to visualize the cells of interest. Both of these reporter 
proteins are fluorescent, but each of them have certain unique properties and structural 
differences that can affect the way they can be used in experiments. 
Ever since the first isolation of GFP from the jelly fish Aequorea Victoria by Shimomura 
et al. (1962), the protein and its variants have been extensively used as reporters for 
visualization of various cell types, including mammalian neurons (e.g. Cowley et al., 
2001; van den Pol et al., 2009). Numerous variants have also been engineered, there 
among EGFP, which contains chromophore mutations that makes the protein 35 times 
brighter than the wild type and is codon optimized for higher expression in mammalian 
cells (Zhang et al., 1996). Nevertheless, initial pilot experiments (data not included) 
showed that endogenous EGFP fluorescence was greatly reduced in tissues treated with 
conventional formaldehyde based fixatives. This is most likely caused by the creation of 
cross-links (see section 3.2.2) between the fixative and the EGFP, which nullifies the 
protein’s fluorescence ability (Becker et al., 2012). To counter this limitation, 
immunofluorescence was used to visualize the EGFP. This enabled a robust and reliable 
recovery of the signal, and with the addition of the TSA protocol (see section 3.4.3), the 
signal could be substantially amplified. 
The red fluorescent protein (DsRed) from Discosoma sp. (Dietrich and Maiss, 2002) is 
another extensively used reporter protein. Similar to EGFP, it has undergone several 
enhancements. By introduction of four point mutations (V22M, Q66M, V105L and 
F124M), the “dead-end” green component has been substantially reduced. A dimer has 
been constructed for faster and more complete maturation with greater fluorescent 
brightness, and the fusion of two of these dimers into a tandem dimer (td) has resulted 
in a non-aggregating tag. This enhanced version of DsRed has been denoted tdTomato 
(Shaner et al., 2004). 
Contrary to EGFP, the endogenous fluorescence activity of tdTomato is not lost by tissue 
fixation. However, the fluorescence intensity is greatly reduced when conventional 2.5% 
DABCO in 100% glycerol is used as mounting medium. Introduction of ProLong® Gold 
as mounting medium resulted in virtually full recovery of fluorescence intensity and 
added the benefit of increased resistivity against photobleaching (see section 3.6.2).  
3.2 TISSUE PREPARATION 
Successful ISH and IHC assays rely intensely on proper tissue preparation. Fresh frozen 
tissues are appropriate for ISH (Dagerlind et al., 1992), and could potentially also be 
used in IHC. However, to be able to draw accurate spatial conclusions, it is necessary 
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that antigens in the tissue are immobilized. Many antibodies are also raised to recognize 
the covalently bound fixative-protein epitope. Therefore, the majority of immuno-
histochemical experiments are conducted on fixed tissues. 
In the studies included in this thesis, fresh frozen tissues have exclusively been used for 
ISH experiments, whereas all IHC experiments have been conducted on fixed tissues. It 
should be noted that a single fixation protocol does not suit all antibodies, and for 
optimal visualization of the targets, different protocols had to be used. The differences 
in these protocols and their implications are discussed in the following sections. 
3.2.1 Fresh frozen tissues 
For the process of any kind of postmortem tissue conservation, it should be noted that 
enzymatic activities and cellular processes will continue, even after blood circulation has 
ceased. This includes, ribonuclease (Kunitz, 1939) activity, which breaks down poly 
ribonucleotides (Findlay et al., 1961; see also Cuchillo et al., 2011), i.e. the target mRNA 
in ISH experiments. Therefore, it is important that tissue is frozen (a process that 
abolishes enzymatic activity) as soon as possible after euthanasia. 
Tools that come in direct contact with the brain should also be free from ribonuclease. 
This is easily achieved by cleaning them in bleach or other commercially available 
nuclease decontamination reagents like RNase AWAY™ or RNaseZAP®. To minimize 
enzymatic activity prior to freezing, the brain can also be dissected into ice-cold saline 
containing ribonuclease inhibitors. By these precautions, up to four brains can been 
dissected sequentially and frozen together without any apparent loss of ISH signal, in 
our experience. 
Theoretically, any rapid freezing techniques could be used. However, most techniques 
are less practical. For instance, dry ice in isopropanol provides rapid freezing but 
submerging a brain into a liquid makes subsequent mounting, embedding and storage 
challenging, carbon dioxide gas is difficult to manage in animal facilities and extremely 
fast freezing with liquid nitrogen often cause the brains to crack. The brains are best 
frozen mounted on aluminum foil, directly on dry ice. To make the freezing process more 
rapid, dry ice can also be crushed into fine powder and poured over the brain. 
3.2.2 Fixed tissues 
Cross-linking and coagulating fixatives are two types of fixatives extensively used in 
histology. Coagulating fixatives are not used in the studies included in this thesis and 
therefore the following section only focuses on cross-linking based fixation protocols. 
These fixatives are based on chemical reagents that react with the tissue and 
consequently polymerizes. They create, as the name suggests, cross-links and thereby 
preserve antigen positions and prevent their degradation. These cross-links also makes 
the tissue more rigid and easier to handle during subsequent staining protocols (see 
Ramos-Vara, 2005). 
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To obtain high quality immunostainings, it is crucial that the amount of cross-link is 
optimal. If the cross-link density is too high, antigens will be compromised and antibody 
penetration will be hindered. On the contrary, if the cross-link density is too low, 
antigens might not be preserved well and could even be washed away when processed 
for immunostaining. As mentioned earlier, many antibodies are raised to recognize a 
part of the protein that is cross-linked with the fixative. Therefore the choice of the 
chemical reagent that constitute the fixative is also important, as the wrong chemical 
would fail to give raise to the specific epitope recognizable by that specific antibody.  
The cross-link density created by the fixative is determined by the fixative’s composition 
and the fixation time. Aldehyde-based fixatives, in particular formaldehyde, is the most 
commonly used and the majority of the experiments in this thesis were performed on 
tissues from animals that were transcardially perfused with a 4% formalin and 0.2% 
picric acid-based fixative diluted in phosphate buffer according to Zamboni and 
Demartino (1967). This fixative worked very well with most of the antibodies used in 
these studies. It is, however, not appropriate for preserving smaller peptides like i.e. the 
neuropeptide thyrotropin-releasing hormone (TRH) which only consists of three amino 
acids.  
To successfully stain for TRH in mouse brains, a final concentration of 0.05% 
glutaraldehyde had to be included in the fixative, similar to what was used by Horjales-
Araujo et al. (2014) in rat brains. Contrary to formaldehyde, glutaraldehyde side chains 
will also polymerize and thereby create a denser cross-link, which prevents smaller 
peptides from being washed out. Unfortunately this fixation will also leave behind a 
much higher degree of free aldehyde (-CHO) groups, bound to the tissue. These free 
aldehyde groups can react with the tissue and give rise to green auto-fluorescence and 
radically reduce the signal-to-noise ratio. Free untreated aldehydes can also bind 
antibodies during subsequent antisera incubations and substantially reduce the quality 
of the immunostaining. To prevent this, tissues fixed with glutaraldehyde must be 
blocked with for instance 0.1% sodium borohydride (Clancy and Cauller, 1998) before 
freezing. 
For even smaller molecules, like amino acid neurotransmitters, addition of 0.05% 
glutaraldehyde does not suffice. To obtain successful immunostainings against 
serotonin (compare Paper II) and γ-aminobutyric acid (GABA; compare Paper III) a 
cacodylate-based fixative containing 5% glutaraldehyde was used according to Yamada 
et al. (2007). Tissue was subsequently treated with 1% sodium borohydride. The high 
density cross-links created by this fixation protocol also affected antisera penetration 
substantially and much longer incubation times had to be applied. 
Spine analysis of TIDA neurons conducted in the second study of this thesis, posed a 
different kind of challenge. In this case, ultrastructural preservation of the cell was the 
most crucial. By adding sucrose and 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
  23 
acid (HEPES) to the standard 4% formalin based fixative, as suggested by Fasoli et al. 
(2017), the spine morphology of the neurons could be properly preserved.  
3.2.3 Colchicine pre-treatment 
Neurochemical characterization of cell populations by IHC largely relies on visualization 
of target peptides in the cell body. Certain neuropeptides (and their precursors), 
however, are rapidly transported to the axon terminal in order to be released, and 
therefore cannot be visualized in the cell body in naïve animals. This axonal 
transportation can be inhibited by some neuronal toxins. Colchicine is one such toxin, 
which results in accumulation of neuropeptides in the soma enhancing its visualization 
by IHC (Hökfelt and Dahlström, 1971). It is derived from the plant Colchicum 
autumnale, and was first isolated by Pelletier and Caventou (1820) and purified and 
named by Geiger (1833). Colchicine inhibits the polymerization of tubulin into 
microtubules (Eigsti, 1938), which form the cytoskeleton of axons, and thereby 
suppresses microtubules-dependent axonal transportation. 
As colchicine disrupts the cytoskeleton, the cell morphology is also altered (Eigsti, 1938) 
and detectability of axons and dendrites are reduced. Different neuronal populations 
have also shown different susceptibilities to colchicine (Goldschmidt and Steward, 
1982) and both increased and decreased transcription levels have been observed in 
certain neuronal populations (Cortés et al., 1990). Thus, data collected from colchicine-
treated animals should be interpreted with caution. The neuronal populations identified 
under colchicine treatment which are included in the studies in this thesis, have been 
validated in other studies. Thus, these undesirable side effects were taken into account 
in order to validate the conclusions in this thesis. 
3.3 IN SITU HYBRIDIZATION 
Expressed mRNA can be detected directly on tissue sections, using labeled nucleotide 
probes complementary to the mRNA of interest (Pardue and Gall, 1969). Classically, 
this in situ hybridization (ISH) technique has been performed with several different 
strategies in regards to probe design and detection methods, where each method has its 
own benefits and drawbacks (Jin and Lloyd, 1997). However, relative to quite recent 
development of the RNAScope platform (Wang et al., 2012), ISH has been a difficult 
method with long and tedious procedures that require optimization for individual 
probes. 
Because of this, ISH targeting mRNA is rarely used in clinical settings, despite the 
technique’s ability to detect pathological biomarkers (Warford, 2016). However, the 
strength of the technique is clearly apparent in initiatives like the Allen Brain Institute 
where ISH is used to create a full expression map of different transcripts in the mouse 
brain. In research settings ISH can serve as a substitute to immunohistochemistry (see 
section 3.4), whenever there is a lack of specific antibody, or if the target has a subcellular 
location that makes it difficult to identify.  
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Additionally, ISH is sometimes also used to confirm that a specific antisera used in 
immunohistochemistry (see section 3.4) is targeting the right cell population. It should 
however be emphasized that these two techniques are inherently different; while ISH is 
targeting a transcripted mRNA, IHC is (usually) targeting a translated protein. The 
correlation of the transcriptome and the proteome depend on a series of regulatory 
processes, including mRNA stability (Salton et al., 1988) and degradation (Casey et al., 
1988), and a cell’s transcriptome and proteome is not always coupled.  
In the studies included in this thesis, two different ISH methods, i.e. radioactive oligo 
probes and RNAScope®, have been used as a complement to validate observations made 
by immunofluorescence. These two methods are discussed in the following sections. 
3.3.1 Radioactive oligo probe in situ hybridization ISH 
This method identifies the target mRNA with several complementary DNA oligo probes. 
Each oligo probe consist of around 50 bases of complementary DNA and a 10-15 base 
long 35S-labeled poly-A tail at the 3’-end (Dagerlind et al., 1992; Wilcox, 1993). 
Following hybridization, the radioactive beta particles originating from the probe, is 
detected by exposure to a nuclear track plate emulsion, which after development 
generates silver grains (Buongiorno-Nardelli and Amaldi, 1970). Exposure can last from 
a couple of days to a couple of weeks (Woodruff, 1998). Although silver grains are visible 
in bright field microscopy at high magnifications, they are usually investigated at lower 
magnification powers with dark field microscopy (see section 3.6.1). As this provides a 
wider field of view, anatomical orientation is easier.  
By increasing the number of oligo probes, signal intensity can be enhanced linearly 
(Young et al., 2016). It should, however, be noted that the poly-A tail creates a steric 
hindrance and oligo probes cannot target sequences that are overlapping or positioned 
too close to each other. Great consideration must also be taken into the design of the 
oligo probe in regards to its sequence and GC-content, to minimize the risk of 
hybridization of the probe to untargeted sequences. Signal intensity can also be 
enhanced by increased exposure time. This, however, has a negative impact on the 
background noise caused by cosmic radiation and poorly hybridized probes. The method 
is difficult to multiplex. 
More recently, radioactive ISH has become less popular due to several reasons. It is a 
long process and involves many steps, where a single poor condition in one step 
jeopardizes the entire experiment. There are several mid-process control assays, like 
counting radioactivity of the labeled probe or confirming hybridization with 
phosphoimaging. Although quite valuable check-points, these controls only provide 
limited validation and true success of the experiment can only be established at the very 
end, under the microscope. 
The use of radioactive materials is also regulated and the method is only allowed to be 
executed by trained personnel, in designated certified areas. Furthermore, the vast 
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increase of antisera availability has led to a decreased demand for ISH techniques in 
general, which in turn has led to substantially increase of material and equipment costs 
and availability. The bankruptcy of Kodak in 2012, the company that provided two of 
the key components, i.e. the NTB emulsion and the D-19 developer, was the final nail in 
the coffin for radioactive oligo probe ISH.  
Nevertheless, radioactive oligo probe ISH was successfully used in study I to confirm 
expression of calcium binding proteins in the arcuate nucleus and address discrepancies 
observed among different parvalbumin antisera. 
3.3.2 RNAScope® 
RNAScope® is a proprietary platform, owned by ACD Bio Techne, and quite a recent 
addition to the ISH repertoire. The technique uses oligo probes to target mRNA and 
utilizes several intermediate DNA amplifier fragments to generate a highly amplified 
signal. The platform is provided as kits, that are available in both chromogenic and 
fluorescence. The entire process can be done in one or two days, and fluorescence kits 
are easily multiplexed. Probes are also proprietary. As of 2018, the company provides 
over 10,000 unique probes targeting several species including human, bovine, dog, 
monkey, mouse, pig, rabbit, rat and zebrafish. Custom probes are designed and made 
available for an additional charge. 
Overall, RNAScope has addressed many of the issues previously associated with ISH 
(see above). The amplification steps render very favorable signal-to-noise ratios, 
fluorescence multiplexing is straight-forward and results are acquired within a day or 
two. The cost, however, remains a major drawback which greatly limits how much it can 
be used. From a cost-benefit point of view, mapping and neurochemical characterization 
of larger brain regions, like hypothalamus, cannot currently be justified with this 
method.  
The fact that all the components, including the probes, are proprietary can also lead to 
concerns as the researcher has a very limited knowledge and control over the assay. This 
has truly been an issue in several assays, where a specific probe has failed to identify the 
target. Yet, RNAScope has a promising future and the potential to become a standard 
method in many laboratories. 
As mentioned earlier, it is necessary to validate the EGFP expression in the BAC 
transgenic animal models, and due the lack of reliable antibodies (which is one of the 
reasons why transgenic animals are used in the first place), this had to be done through 
ISH. Unfortunately, endogenous EGFP fluorescence is lost when tissue is processed for 
ISH, and multiplex targeting is therefore necessary. RNAScope has provided the means 
to properly conduct these validations.  
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3.3.3 Other multiplex in situ hybridization techniques 
It should be mentioned here that before the introduction of RNAScope, which is a 
method that only became available lately, many efforts were spent seeking a successful 
multiplex fluorescence ISH procedure to validate the BAC transgenic animals. First, 
multiplex oligo probe ISH, where one probe (targeting Drd2) labeled with biotin and the 
other probe (targeting Egfp) labeled with digoxigenin, or vice versa, and subsequently 
detected with fluorescent labeled streptavidin and antisera against digoxigenin, was 
evaluated. Enzymatic amplification steps by introduction of horseradish peroxidase and 
alkaline phosphatase conjugates were also assessed. 
Each probe, by itself, yielded satisfactory results, but would fail in multiplex. Multiplex 
hybridization followed by sequential detection also failed to detect both targets 
simultaneously. Next, sequential IHC/ISH, where EGFP was detected by the means of 
IHC and Drd2 was detected by the means of ISH, was evaluated with no success, 
regardless if the sequence started with IHC or ISH. Finally, usage of riboprobes 
spanning around 500 bases of the target gene was evaluated, also with no success. 
The fact that Drd2 has a relatively low expression level in the hypothalamus (compare 
Paper V) has a crucial role in these failures as detection is not possible with suboptimal 
conditions and there is little margin for methodological compromises. It was therefore 
concluded that it is not possible to combine the material and methods of the two 
detection methods evaluated in such a way that detectable signal intensity for both 
targets are preserved. Although the above mentioned approaches might pose a viable 
strategy for multiple detection of other target pairs that are expressed at higher levels 
and are less sensitive to suboptimal conditions, RNAScope nowadays provides an easier 
and more straightforward approach, and therefore renders these strategies obsolete.  
3.4 IMMUNOHISTOCHEMISTRY 
Labeled antibodies can be used to target specific antigens on tissue for visualization 
(Coons et al., 1941; Coons and Kaplan, 1950). This is known as direct 
immunohistochemistry. As this direct detection method involves labeling of antibodies, 
a process that result in loss of rare and precious immunoglobulins, it is rarely used. Most 
commonly, an indirect detection method that utilizes labeled secondary antibodies that 
recognize the primary antigen-complementary antibody, is used (see Ramos-Vara, 
2005). Signal intensity can be amplified by conjugating an enzyme to the secondary 
antibody, which synthetizes a detectable precipitate or fluorophore. When detection is 
done with fluorescent dyes, the technique can also be referred to as 
immunofluorescence. In the studies included in this thesis, immunofluorescence 
techniques have been used to identify and profile cells, map neuronal populations and 
investigate neuronal connectivity. 
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3.4.1 Monoclonal and polyclonal primary antibodies 
Primary antibodies are raised by immunizing a host animal with a specific antigen. The 
host is subsequently bled and the sera, which contain the antibody of interest, as well as 
other antibodies, is separated. To minimize background noise and reduce unspecific 
binding, the immunizing antigen can be used to purify and concentrate the antibody of 
interest from the sera. When immunizing an animal with i.e. a peptide, the host will most 
likely produce antibodies against several different regions of it, and purification will 
yield a mixture of several antibody clones, i.e. a polyclonal mixture, where different 
clones recognize the same target antigen, but not necessarily the same epitope (see 
Ramos-Vara, 2005).  
Polyclonal antisera have two major disadvantages. First, since the mixture of antibodies 
in the sera is unknown, using different bleeding will result in different antibody 
mixtures, and unwanted variability is inevitably introduced in the experiment. Second, 
some assays, i.e. when targeting a specific phosphorylation site of a protein, require a 
single antibody that only recognizes a specific region of the protein. In such case, 
detection would not be possible with a polyclonal mix. 
To circumvent these issues, the process of creating monoclonal antibodies has been 
developed, where antibody producing B-cells from the spleen of the immunized host is 
fused to myeloma cells to create hybridomas (Schwaber and Cohen, 1973; Köhler and 
Milstein, 1975). The hybridomas are then separated and a single clone that produces the 
antibody of interest is selected. A hybridoma clone will only produce a single type of 
immunoglobulin against a single epitope. When the abundance of the target is low, it is 
more favorable to use polyclonal antibodies that recognize multiple sites of the target 
and thereby yield a stronger signal (see Ramos-Vara, 2005). Monoclonal antibodies, on 
the other hand, can be produced in larger quantities and have less batch-to-batch 
variability. 
3.4.2 Secondary antibodies 
As primary antibodies originate from a specific species, secondary antibodies are raised 
to recognize the species specific constant region of primary antibodies. Purified 
secondary antisera against different species, conjugated to a variety of enzymes or 
fluorescent dyes are widely available. By using primary antibodies from different 
species, it is possible to multiplex an immunofluorescence assay and detect multiple 
targets on the same tissue at the same time. Caution must, however, be taken against 
species cross-reactivity (see Ramos-Vara, 2005). 
3.4.3 Tyramide Signal Amplification 
Following oxidation/radicalization, tyramine can chemically bind to solid substrates 
(Gross and Sizer, 1959) and since this reaction is short-lived, tyramine will stay in close 
proximity to the site of reaction (Hayat, 2002). This process was adapted to histology by 
Adams (1992) who used biotinylated tyramide together with horseradish peroxidase 
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conjugated antisera to create biotinylated epitopes on the tissue. Biotinylated epitopes 
were subsequently visualized with labeled avidin, yielding a highly amplified signal. 
A less complex variation, where fluorescein (rather than biotin) is conjugated to 
tyramide, is used in the studies in this thesis. Test assays (data not included) have 
showed that this more direct tyramide signal amplification (TSA) approach generates 
about ten-fold stronger signal than conventional indirect fluorescence detection 
methods and the use of biotinylated tyramide does not improve this further. On the 
contrary, using biotinylated tyramide sometimes yielded a less intense signal, most 
likely since the size of the avidin-HRP caused steric hindrance and prevented further 
amplification.  
 
With TSA, it is possible to use antisera at ca. ten time lower concentration, without losing 
signal intensity. The use of lower concentration also leads to decreased background 
caused by unspecific binding. This makes it beneficial to combine TSA with unpurified 
polyclonal antisera, as lower antisera concentration result in a better signal-to-noise 
ratio. TSA is also particularly well suited for detecting low abundant targets, where 
stronger signal cannot be generated with higher immunoglobulin concentrations.  
Due to the nature of the method, the resolution of the staining is, however, reduced. This 
is not visible at lower magnifications, but at higher magnifications, staining can appear 
“granular” and TSA is therefore less suitable for investigating finer structures of the cell. 
It has also been less successful when combined with primary antisera targeting the 
extracellular portion of membrane proteins as the staining appears diffuse. Compared 
to the cytosol, the extracellular matrix probably presents fewer reactive sites for the 
reactive tyramide to bind to, which causes a longer trace and gives rise to the diffuse 
staining pattern. 
Figure 8. Basic principle for tyramide signal amplification. Horseradish peroxidase catalyzes the 
reaction to create reactive tyramide that can covalently bind to the tissue. This leads to deposition of a large 
number of fluorescent molecules in close vicinity of the target antigen, greatly amplifying the signal. HRP, 
horseradish peroxidase; GFP, green fluorescence protein; F, fluorescein isothiocyanate.  
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3.5 ELECTROPHYSIOLOGY 
The different ion concentration between the inside and outside of a cell, produced 
mainly by actions of the Na+/K+-ATPase pump, generates a voltage difference across the 
membrane. The driving force thus created is particularly important in cells with 
excitable membranes, such as neurons, and can be used to produce action potentials, as 
described by Hodgkin and Huxley (1952), which in turn allow for the electrical 
triggering of chemical neurotransmission between neurons. In addition to a cell’s 
morphology and transcriptional profile, knowledge of its active and passive membrane 
properties and electrophysiological behavior is thus necessary for understanding how 
ensemble of neurons work in networks to ultimately control the organism. 
The electrophysiology of hypothalamic neurons is not the main focus of this thesis. 
Nevertheless, electrophysiological methods and properties are complementary to the 
molecular biological methods and properties. They provided data necessary for the 
overall understanding of the cell and how it respond to neurotransmitters and/or 
neuromodulators. Electrophysiology was also an integral part of some of the 
experimental procedures, as a mean to identify and fill TIDA neurons with markers for 
subsequent histochemical visualization of the cell (see below). These methods are briefly 
discussed in the following sections. 
3.5.1 Whole-cell patch clamp recording 
The electrophysiology of individual cells can be monitored by whole-cell patch clamp 
recordings where a glass micropipette with an electrode is used, to record the cell’s active 
and passive membrane properties and how they change in response to messenger 
molecules (Neher and Sakmann, 1976; Hamill et al., 1981). In these experiments, the 
pipette, drawn to a fine open tip, is brought into direct contact with the cell membrane 
so that a so-called giga-seal is establish. The seal is then ruptured using suction, which 
gives the pipette direct access to the cell’s interior. This is known as the whole-cell 
configuration. 
In this configuration, electrical events across the membrane can be studied. By clamping 
the voltage, the current crossing the cell membrane can be recorded (Cole and Moore, 
1960). Alternatively, the current can be clamped, and the voltage is consequently 
recorded. In the whole-cell configuration, it is important that the internal solution of the 
patch pipette has the right composition in regards to ions, pH and osmolality, and that 
it is as similar as possible to the cell’s cytosol. Otherwise, the risk of dialysis is imminent, 
which can lead to electrical artefacts and cell death. 
3.5.2 Filling patched neurons  
Molecules added to a patch pipette’s internal solution can be transferred into a cell 
during whole-cell patch clamp recordings. This process has been used to fill recorded 
cells with markers for subsequent IHC and visualization of the recorded cell, which 
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enables identification of both the intrinsic electrical properties and neurochemical 
identity of the same cell. After successful recording, the patch pipette from a filled cell 
must be removed in such a way that the cell body is not damaged. 
To be able to completely fill and recover a patched neuron, in regard to its axon and 
dendritic tree, several parameters must be optimized. A patched cell can be filled with 
several different kinds of markers. It is important that the marker of choice does not 
pose any toxic effects to the cell and leaves the electrical recordings unaffected. 
Fluorescence dyes like Lucifer Yellow or different versions of Alexa dyes are useful for 
direct visualization, but are not suited if the slice is to be fixed for immunohistochemical 
investigation. Biotin-derivatives that can be detected with avidin are, on the other hand, 
well suited for this purpose. In the studies included in this thesis, neurobiotin has largely 
been used. Biocytin has also been investigated. No apparent differences could be 
observed between these two markers. 
Other factors that affect the staining quality is the concentration of neurobiotin in the 
patch pipette (neurobiotin concentration), the time the pipette is allowed to fill the 
neuron by passive diffusion (fill time) and the time the slice is allowed to recover before 
fixation (relaxation time). For best visualization of TIDA neurons, the neurobiotin 
concentration was optimized to 0.2%, fill time to 60 min, and relaxation time to 15 
minutes. It should be mentioned that these parameters are not necessarily optimal for 
investigating other neurons with different cell morphology. 
3.5.3 Staining filled neurons 
After a cell is filled, it has to be fixed, stained and processed for IHC. As 
electrophysiological slices (ca. 250 µm in these studies) are substantially thicker than 
conventional sections used for histology (ca. 14 µm), several procedural steps must be 
reconsidered for obtaining adequate results. A thick slice will result in considerably 
higher levels of fixative induced fluorescence and will make immunoglobulin 
penetration more difficult. Therefore, the slice should not be fixed for longer than 18 
hours. All incubation and wash times must also be increased to ascertain adequate tissue 
penetration. 
In the studies included in this paper, recorded cells have been successfully stained with 
both fluorescence and chromogen dyes. The latter utilized HRP conjugated streptavidin 
with 3,3-diaminobenzidine (DAB) and nickel as substrate. Chromogen detection has the 
benefit of being prone to photobleaching (see section 3.6.2), but cannot be used with 
confocal microscopy (compare section 3.6.3), nor with multiplex immunostaining. It 
was initially theorized that resistance to photo bleaching, would be more favorable and 
make it easier to maintain and identify finer structures like axons and spines. This, 
however, turned out to be false, mainly due to the complexity of the structures and the 
thickness of the slice. Nevertheless, data from DAB-Ni stained TIDA neurons showed 
that photobleaching did not have a negative impact on the reconstructions of the 
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dendritic trees of TIDA neurons (compare section 3.7.2). It should, however, be noted 
that it is likely that photobleaching will impact reconstructions of neurons possessing 
more complex dendritic trees negatively. 
3.6 MICROSCOPY 
The majority of experiments included in this thesis heavily rely on light microscopy, and 
several different microscopy techniques have been used to address different questions. 
These different microscopy techniques are discussed in the following sections. 
3.6.1 Bright field and dark field microscopy 
Although it has undergone major technological improvements in regards to both 
construction and optics, the basic principle of bright field microscopy has remained the 
same since its first description by Antonie van Leeuwenhoek in the 1600s (see 
Houtzager, 1983). In the studies in this thesis, it has been used at low power to 
investigate non-fluorescent tissues and to determine Bregma levels of tissue sections, 
counter-stained with toluidine blue, an acidophilic thiazine metachromatic dye (Augulis 
and Sepinwall, 1969; see also Sridharan and Shankar, 2012). At higher power, it has 
been used to investigate the morphology of filled TIDA neurons, which have been 
stained with DAB-Ni. The technique is rather straight-forward, although, it should be 
emphasized that correct Köhler illumination (Köhler, 1893) greatly improve image 
quality. 
 
In dark field microscopy (see e.g. Edmunds, 1877), a method used by Fritz Schaudinn 
and Erich Hoffmann in 1905 to identify the syphilis’ causing bacterium, Treponema 
pallidum (Schaudinn and Hoffmann, 1905), the light that hits the specimen is aligned 
and angled in a way so that the amount of transmitted light is minimized. Only scattered 
light is collected (see Figure 9). This technique can improve image contrast dramatically 
and is therefore commonly used to visualize transparent specimen. Dark field 
microscopy is also used when investigating radioactive ISH experiments, as sparsely 
positioned, small sized, silver grains are difficult to detect in bright field, but will scatter 
Figure 9. Basic concept of bright field and dark field microscopy. In dark field microscopy, the majority 
of the transmitted light is filtered out, and only scattered light is collected. Adapted from a drawing from the 
internet with unknown author. 
Dark Field Bright Field 
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light very well. Although this technique makes the silver grains readily detectable, it is 
very sensitive to impurities, as dust on the cover glass, which also scatters light, will 
cause interference. 
3.6.2 Fluorescence microscopy 
Investigation of fluorescent dyes is usually done with epifluorescence microscopy, where 
the specimen is illuminated from above. This technique utilizes the fact that fluorescent 
molecules, when illuminated, will emit light of lower frequency than those they absorb. 
As the excitation and emission lights are different, they can be filtered, so that only the 
emitted light is collected, and thereby, only the structure of interest, which has been 
labeled with the fluorescence dye, is visualized. Using different fluorescent dyes with 
separated excitation/emission wavelengths, it is possible to stain different structures, 
visualize them individually and superpose them to create a multiplex image. 
Although recent technical developments have made it possible to use single wavelength 
light sources produced from light-emitting diodes, the majority of microscopes, 
including the ones used in the studies in this thesis, uses a broad spectrum light source 
and rely on filter sets for light separation. Correct dye/filter set matching is crucial for 
successful image acquisition. If there is a mismatch in the excitation wavelength, the dye 
is not excited and little light is emitted, and if there is a mismatch in the emission 
wavelength, emitted light is not collected. 
Unless intentional, which is the case when utilizing double filters for simultaneous 
observation of different dyes in the oculars, filter sets that fail to separate the light from 
different dyes, can have a more serious outcome. This phenomenon, known as “bleed-
through”, will cause fluorescence signal to be attributed to the wrong structure, and 
thereby lead to false conclusions. Additional knowledge about the spatial distribution of 
the stained structures can provide necessary information to handle this. For instance, 
while neurobiotin will fill the entire cell, tyrosine hydroxylase (TH) is mostly void from 
the nucleus. TH signal in the nucleus can therefore alert the observer that the image is 
suffering from bleed through.  
Lack of optical control in the z-axis leads to another type of concern in fluorescence 
microscopy. When the light hits the specimen, all fluorescent molecules absorbing the 
specific wavelength will get excited, regardless if they are in the focal plane or not. As the 
reflected light originates from both in-focus and out-of-focus structures, the image is 
rendered blurry. This interference can also causes fluorescence signal from two distinct 
structures, which are superposed in the plane of depth, to appear as a single structure. 
Together, these caveats make conventional florescence microscopy less suitable for co-
localization studies. 
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3.6.3 Laser scanning confocal microscopy 
Laser scanning confocal microscopy was patented by Marvin Minsky (1957) as a 
microscopy apparatus providing the “means for producing a point source of light” and 
an “optical system capable of rejecting all scattered light except the emanating from 
the central focal point”, i.e. an apparatus that made it possible to optically slice a 
specimen. This is done by introduction of a spatial pinhole that blocks out the light that 
is out focus. As a large portion of the light from the sample is blocked, a sensitive 
detector, usually a photomultiplier, is used to transform the light to electrical signal 
which can be handled by a computer. 
To acquire a multidimensional image, the point beam has to scan across the sample. If 
the sample is scanned both laterally, and horizontally, the data can be put together into 
a 3D image. When multiple fluorophores are used, they can either be excited 
simultaneously or sequentially, depending on the setup of the microscope. Simultaneous 
excitation substantially reduces the scan time. This strategy can, however, generate 
bleed-through (see section 3.6.2) and should be avoided. Slower scan speeds also 
provide better signal-to-noise, but in multidimensional acquisitions can lead to 
bleaching. It can also become time-consuming to an extent that makes the acquisition 
unfeasible (compare Figure 10). 
By the means of optical slicing and separation of the fluorescence signal through 
sequential scanning and filtering, confocal microscopy provides the necessary criteria to 
reliably separate multiple structures in space. Co-localization should therefore only be 
established with this technique.  
3.6.4 Airyscan super resolution microscopy 
In recent years, several microscopy techniques, like stimulated emission depletion 
microscopy (Hell and Wichmann, 1994), stochastic optical reconstruction microscopy 
(Rust et al., 2006) or photoactivated localization microscopy (Betzig et al., 2006), have 
been developed which makes it possible to visualize structures with a higher resolution 
than is imposed by the diffraction limit (about 250 nm for green light), as proposed by 
Abbe (1873). The Airyscan detector from ZEISS (Huff, 2015) is another recently 
developed technique, which has been used in the second study included in this thesis. 
Airyscan utilizes a detector for confocal microscopy, consisting of an array of 32 
photomultiplier tubes, where each detector element work as a single pinhole. By 
combining knowledge about the beam path and the spatial distribution of the detectors, 
improved signal-to-noise ratio and super-resolution is acquired (see Figure 10). Other 
advantages of the Airyscan system is that it does not require any changes to the staining 
protocols, the acquisition time is not increased and specimen is not bleached more than 
what is the case with conventional confocal microscopy. 
A major disadvantage is that the image files generated by the acquisitions are 32-times 
larger, and that these images need to be post-processed to generate the final super 
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resolution image. Processing thicker stacks is CPU-consuming and pushes most desktop 
computers to their limits. Both acquisition and processing of larger regions of interest 
by the means of tiling require workstation-class computers. Computer power is today a 
limiting factor that will likely become obsolete in a near future. 
 
3.6.5 Photobleaching of fluorescence samples 
Photo-bleaching, or fading, caused by a reaction between the excited fluorophore and 
molecules in the environment, like oxygen, is a major concern when working with 
fluorescence samples. This is minimized by limiting the exposure to light and reducing 
its intensity, which unfortunately, also reduces the specimen visibility. Usage of anti-
fading mounting medium can also significantly minimize photo-bleaching (Ono et al., 
2001). Stained samples should be stored at -20°C, as lower temperatures will slow down 
the reactions and preserve the samples for longer period of time. Many samples included 
in this thesis have retained their fluorescence after several years of storage at this 
temperature.  
3.7 ANALYSIS 
In this section, certain aspects of analytical methods used have been discussed. 
3.7.1 Close apposition and co-localization 
Although confocal microscopy provides the criteria necessary to differentiate 
multidimensional structures (see section 3.6.3), this differentiation can be completely 
nullified by incorrect data handling and presentation. As we lack the true ability to 
present data in 3D, it is projected in 2D. Maximum intensity projections are commonly 
utilized to visualize stacks of confocal micrographs. These micrographs must be used 
Figure 10. Increased resolution with Airyscan confocal microscopy. High power maximum intensity 
projection confocal micrographs of neurobiotin filled (green) TIDA neuron, immunostained for tyrosine 
hydroxylase (red), visualizing a putative synapse from the ventrolateral aspect of the arcuate nucleus and 
provide anatomical substrate for TIDA neurons innervating other dopamine neurons (n = 1). Image acquired 
with a ZEISS Airyscan LSM 700 microscope with a 63x oil objective at 9x zoom. To achieve optimal signal-
to-noise ratio, a pixel time of 0.11 ms was utilized. Compared to confocal (left), the Airyscan processed 
image (middle) is smoother, with less noise and with higher resolution. After deconvolution (right), the 
subcellular distribution of neurobiotin and tyrosine hydroxylase can be identified. Although these settings 
are optimal for image quality, they are not practical as it would be too time consuming to scan a 30 µm 
portion of a dendrite in 3D (which was used for spine analysis in study II). Grid size = 1 µm. 
Confocal Airyscan Airyscan + Deconvolution 
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with extreme caution, as two structures separated in space, in the plane of depth, can 
appear as a single object, similar to what is observed in the oculars. Likewise, depending 
on the angle, objects that are far away in the plane of depth, can appear closer than they 
really are. This must be taken into consideration during data analysis, and close 
appositions and co-localizations must always be confirmed in a single optical slice and 
in all three planes. 
3.7.2 Reconstruction of neurons in Neurolucida 
Camera Lucida, which was patented by William Hyde Wollaston in 1806 (see Marien, 
2014 p.7), provides the means to manually draw and create a proportionally accurate 
record from a live image. This has been a major advantage in neuroscience as image 
acquisition that covers the entire axonal and dendritic tree of neurons has not been 
technically possible. Thus, camera lucida drawings have for decades been a major 
technique for histologists to record and present their microscopy data. The computer 
software MBF® Neurolucida (Glaser and Glaser, 1990), is essentially a computer aided 
version of camera lucida, and provides the means to trace neurons from a live 
microscope image. This live image tracing does, however, have certain disadvantages, 
especially, on fluorescent specimens. 
Photo-bleaching, as described previously (see section 3.6.5) is a major issue, particularly 
at high power magnifications. This basically means the examiner only has “a single shot” 
to trace a neuron, and optimization and future confirmation of a trace is thereby not 
possible. Photo-bleaching can also make tracing challenging when multiple neurites are 
in the same field of view, as all neurites are bleached when one neurite is being traced. 
This has been less of an issue for TIDA neurons due to their less complex dendritic tree. 
The thickness and volume of the dendrites can also be integrated when tracing neurons 
with Neurolucida. These estimates depend highly on proper light and camera settings. 
If the signal from the process that is being traced is saturated, the thickness and the 
volume will be overestimated, and if the signal is too weak, they will be underestimated. 
This, together with the continuous bleaching of the tissue can make it difficult to 
maintain a uniform tracing, and a certain level of error is introduced in the data. In less 
complex structures, however, this error is not particularly significant. 
It should be mentioned that recent developments in tissue clearing, like CLARITY 
(Chung et al., 2013) or iDISCO (Renier et al., 2014), and light sheet microscopy (see 
Elisa et al., 2018), have enabled acquisition of entire mouse and rat brains, albeit at 
lower resolutions. Given the computer power that is available at the time when this 
thesis is being written, handling these huge datasets is problematic. Development, in 
regard to computer power as well as light sheet microscopy resolution, should however 
make it possible to trace entire neurons from acquired micrographs, which should 
resolve many of the live image tracing issues. 
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3.7.3 Spine analysis in Imaris 
The spine analysis that is part of the second study of this thesis has been conducted in 
BitPlane® Imaris. This computer software provides a fully automatic pipeline, which 
rarely generates realistic results, most likely because the algorithms lack the 
sophistication that is necessary to detect complex and highly variable structures like 
spines. Also, the company has mainly used medium spiny neurons from the striatum to 
develop their algorithms. As TIDA neurons exhibit extensions that does not always 
adhere to classical definitions (compare study II), it is plausible that the parameters used 
by the algorithms are not optimal for spine detection in the hypothalamus. 
Using a semi-automatic pipeline, where several steps heavily rely on manually defined 
thresholds, satisfactory results can, however, be generated. As it is not possible to use 
equivalent thresholds across samples and maintain adequate reconstruction of the 
spines at the same time, the analysis can introduce unwanted variability in the results. 
Given the power of the data and observed differences between groups, these variabilities 
are, however, not of a size that would affect the study’s conclusions. 
It should be mentioned that BitPlane® is continuously developing their computer 
software and future versions might provide faster and more accurate solutions. 
However, as Imaris is a proprietary software, certain aspects of the functions, 
parameters and algorithms used in the program will remain unknown. 
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CHAPTER 4  
RESULTS AND DISCUSSION 
he following sections provide an overview of the results from the studies 
included in this thesis, and discuss the overall implications of them. For a 
complete insight in the results, and comprehensive discussion of the 
individual studies, the reader is referred to the respective communications.  
4.1  TUBEROINFUNDIBULAR DOPAMINE NEURONS 
The anatomical features of male mouse and rat TIDA neurons, at the level of population 
as well as individual cells, including axonal and dendritic arborization, somatic 
parameters and spines, were interrogated in study II, by the means of conventional 
immunofluorescence on brain sections, as well as by the visualization of patch clamp 
recorded neurons filled with marker-molecules. Multiplex immunofluorescence was 
also used to investigate subcellular distribution of glutamatergic and GABAergic 
synapses on TIDA neurons. Together, these strategies enabled us to describe TIDA 
neurons with higher resolution and certainty than what had been done previously. 
Histochemical techniques, in combination with electrophysiology, were also used in 
studies III and IV to investigate if, and how, TIDA neurons are externally modulated by 
various different modulators. In study III, the anatomical substrate for serotonergic 
innervation of TIDA neurons was examined and the electrophysiological changes 
induced by serotonin and selective serotonin reuptake inhibitors (SSRIs) were 
investigated. Similarly, in study IV, a possible mechanism underlying the circadian 
rhythmicity of circulating prolactin was examined, by investigating the effects of 
hypocretin/orexin (H/O) and melatonin on TIDA neurons. 
4.1.1 TIDA neurons are modulated by serotonin, SSRI’s and H/O, but not melatonin 
Studies III and IV present both anatomical and electrophysiological evidence for direct 
effects of serotonin and SSRIs as well as H/O, but not melatonin, on TIDA neurons. 
Other modulatory molecules like TRH (Lyons et al., 2010), prolactin (Lyons et al., 2012), 
oxytocin (Briffaud et al., 2015), and even dopamine (Stagkourakis et al., 2016) have also 
in other studies been identified to modify the electrophysiology of TIDA neurons, in 
T 
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different ways (see Figure 11). For a more detailed description on how the different 
modulators affect the electrophysiology of the TIDA neurons, the reader is referred to 
the respective publication. Together these data show that the central dopaminergic 
control of prolactin secretion is highly susceptible to both physiological and iatrogenic 
modulations.  
4.1.2 Oscillations might protect TIDA neurons from calcium overload 
Ever since the oscillatory firing pattern of TIDA neurons were first identified and 
described (Lyons et al., 2010), the underlying functional explanation for this pattern has 
been under investigation. As adequate suppression of prolactin requires a constant tone 
of dopamine, TIDA neurons must remain active, and release dopamine, over long 
periods of time. During sustained high frequency discharge, excessive calcium influx can 
have damaging effects (Scharfman and Schwartzkroin, 1989; Sloviter, 1989; Iacopino et 
al., 1992), which the cell can counter with calcium binding proteins. This correlation has 
been observed in fast spiking neurons of both hippocampus and cortex (Kawaguchi et 
al., 1987; Kawaguchi and Kubota, 1993).  
Figure 11. Different modulator’s effect on the electrophysiology of TIDA neurons. Schematic drawings 
of in vitro current clamp recordings from TIDA neurons during bath application of different modulators. See 
list for abbreviations. 
Lyons et al., 2010 
Lyons et al., 2012 
Stagkourakis et al., 2016 
Briffaud et al., 2015 
Study III 
Study IV 
Prolactin 
Oxytocin 
Dopamine 
5-HT/SSRI 
H/O 
TRH 
Melatonin Study IV 
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Although TIDA neurons does not discharge in the same high rate as fast spiking neurons, 
they sustain a high level of activity over longer periods of time, and one would therefore 
expect presence of buffers that protect the cell from excessive calcium influx. Yet, our 
investigations in study I could not identify neither calbindin-D28k, calretinin nor 
parvalbumin in rat TIDA neurons. Other studies have identified two members of the 
nucleobindin family, i.e. nucleobindin-1 and nucleobindin-2, to be expressed in TIDA 
neurons (Foo et al., 2008; Tulke et al., 2016). These two proteins are homologous 
multidomain calcium and DNA binding proteins, and were initially identified as 
transcription factors, since they bind DNA fragments in vitro (Miura et al., 1992). Due 
to their expression of the calcium binding EF-hand motif, they could potentially buffer 
calcium as well. 
However, nucleobindin-1 is a pan neuronal marker associated with the Golgi apparatus 
(Tulke et al., 2016) and has been identified to bind G-proteins and function in signal 
transduction (Kapoor et al., 2010). Likewise nucleobindin-2, is many times associated 
with its DNA binding functions and identified by other names like calnuc (e.g. Lin et al., 
2000). It has also been proposed that nucleobindin-2 is cleaved and secreted (Oh-I et 
al., 2006; Stengel et al., 2009a), although it remains controversial if cleavage and 
exocytosis occurs endogenously (Foo et al., 2008, 2010; Stengel et al., 2009b). 
Furthermore, it has been shown that nucleobindin-2 is virtually absent in axon 
terminals (Foo et al., 2008). Thus, these observations provide little evidence for 
nucleobindin proteins to buffer calcium in TIDA axon terminals. 
Although the proteins mentioned above do not account for all calcium binding proteins, 
the data do suggest that TIDA neurons might be able to sustain firing by utilizing an 
alternative mechanism, independent of calcium binding proteins. The quiescence period 
following phasic firing could be the necessary component that gives the cell time to 
handle excessive intracellular calcium, and make it possible for TIDA neurons to sustain 
a constant dopamine inhibition on lactotrophs.  
4.1.3 Morphological properties of mouse and rat TIDA neurons are largely similar 
The morphological features investigated in the second study revealed that mouse and 
rat TIDA neurons exhibit similar properties in regard to their distribution, cell body size 
and axonal and dendritic arborization. Thus, if this finding is generalizable across other 
CNS regions, the larger brain volume in rats is a consequence of higher number of 
neurons, rather than larger cells.  
TIDA neurons of both species showed a preference to extend dendrites towards, and in 
some cases probably into, the third ventricle (see Figure 12). This finding raised the 
question if TIDA neurons are able to circumvent the blood-brain-barrier to access 
different kinds of molecules, like ions or hormones, directly from the cerebrospinal fluid. 
Non-canonical neuronal structural features like somatic spines (e.g. Campbell et al., 
2005) and extension of axons from dendrites rather than from soma (e.g. Herde and 
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Herbison, 2015) were also identified in both mouse and rat TIDA neurons. The 
functional implications of these observations remain, however, to be investigated. 
 
4.1.4 TIDA neurons are more spiny in mice than in rats  
Spine analysis on mouse and rat TIDA neurons revealed species differences. Mouse 
TIDA neurons commonly exhibited a higher density of dendritic spines, compared to rat 
dendrites (compare Table 1). Interestingly, previous investigations have identified 
mouse and rat TIDA neurons to be governed by different network mechanisms. While 
rat TIDA neurons exhibit gap junctions and are electrically coupled, mouse TIDA 
neurons lack gap junctions and fire asynchronously (Stagkourakis et al., 2018a). The 
higher prevalence of spines in mouse TIDA neurons could be related to these other 
observations. See study II for more details about spines on TIDA neurons and their 
differences between mice and rats. 
 
4.2 DOPAMINE RECEPTORS IN THE HYPOTHALAMUS 
In studies V and VI included in this thesis, two transgenic mouse lines were used to 
generate a comprehensive map of cells expressing D1 and D2 receptors in the 
hypothalamus, the pituitary and select circumventricular organs. The neurochemical 
identity of these cells was also investigated. Our data confirm previous reports (e.g. 
Meador-Woodruff et al., 1989, 1991; Mansour et al., 1990; Brouwer et al., 1992; 
Mengod et al., 1992; Yokoyama et al., 1994), and add substantial details. 
Figure 12. Reconstruction of neurobiotin filled rat TIDA neurons. Virtual reconstruction (A) as well as 
polar histograms (B) of the dendritic trees of TIDA neurons illustrates the preference towards the ventricle 
side. See list for abbreviations. Scale bar in (A) = 25 µm. 
Arc 
3V 
Table 1. Comparison of mouse and rat TIDA neurons 
MICE RATS 
Asynchronous firing1 Synchronous firing1 
No gap junctions1 Gap junctions1 
High spine density Low spine density 
1 Original data presented by Stagkourakis et al. (2018a).  
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The expression patterns of D1 and D2 receptors showed a striking contrast. While the 
D2 receptor was widely expressed in the hypothalamus and could be found in many 
hypothalamic nuclei, the D1 receptor expression was sparse and restricted to a few 
areas, suggesting that the dopaminergic control that is exerted on the hypothalamus is 
mainly inhibitory. The suprachiasmatic nucleus, however, constitutes a clear exception, 
as this area contained many D1 receptor expressing neurons, but was completely void 
of D2. 
These dopaminergic inputs (compare section 1.2.2) could proceed from local 
hypothalamic neurons (i.e. A11-A15), or originate from either the mesencephalon (i.e. 
A8-A10) or the olfactory bulb (i.e. A16). The local hypothalamic circuitries could also 
involve auto-receptors. However, the dopamine source providing innervation to the 
hypothalamus was not addressed in these studies, and needs to be evaluated in future 
studies. 
4.2.1 Dopamine receptors on dopaminergic neurons 
The alphanumerical classification of catecholamine neuron, which includes A11-15 in 
the hypothalamus was used to identify dopamine neurons (see section 1.2.2). D2 
receptor was found to be expressed in subpopulations of all these groups. Although 
Drd2-EGFP immunofluorescence could not be found in the A13 dopamine neurons of 
zona incerta, closer examination by the mean of multiplex in situ hybridization could 
identify Drd2 mRNA in this population as well, confirming previous D2 receptor ligand 
binding autoradiography studies (Yokoyama et al., 1994). The lack of 
immunofluorescence in A13 dopamine cells is thus most likely a transgenic artefact (see 
section 3.1.1). As detailed information about the included regulatory elements in the 
BAC construct is lacking, the exact cause of this artefact cannot be identified. 
D1 receptor expressing neurons were also found in subpopulations of A12-A14 
dopamine neurons, but in fewer numbers. Although controversial, previous 
immunohistochemical investigations have identified co-expression of D1 and D2 
receptors in the same cells of striatal neurons (Aizman et al., 2000) as well as avian 
hypothalamic neurons (Chaiseha et al., 2003). Our current results from these two 
studies raise the question if such co-expression also occurs in the mouse hypothalamus. 
Nevertheless, our current data clearly indicate that hypothalamic dopamine control in 
both A12 and A14 dopamine neurons is mainly mediated by the D2 receptor. 
4.2.2 Magnocellular neurons lack dopamine D1 and D2 receptors 
Our data provide little evidence for direct dopaminergic modulation of the 
magnocellular system, as no significant co-expression could be observed with either D1 
or D2, on the magnocellular neurons in the supraoptic or the paraventricular nuclei. 
Surprisingly, EGFP signal resembling axon terminals could, however, be observed in the 
posterior pituitary of Drd1-EGFP mice, but the neurochemical identity of these 
terminals is currently not determined. It should be mentioned that a single vasopressin 
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expressing neuron (i.e. one neuron in one section), was occasionally observed in the 
supraoptic nucleus, but the density of the fibers in the posterior pituitary was too high 
to originate from a single neuron. 
4.2.3 Dopamine receptors are involved in the majority of the hypothalamic-pituitary 
axes 
Dopamine can control endocrine release at hypothalamic and/or pituitary levels. D1 
receptor was only observed in dopaminergic parvocellular neurons (see section 4.2.1), 
and the anterior pituitary was void of D1 receptor. In the hypothalamus, D2 receptor 
was expressed in a subpopulation of both somatostatin and TRH expressing neurons 
whereas in the pituitary lacto-, thyro- and gonadotroph cells expressed D2 receptor. No 
conclusions could be drawn regarding growth hormone-releasing hormone (GHRH) 
expressing neurons in the hypothalamus due to the lack of specific antisera.  
These data indicate a broad role for the D2 receptor in the hypothalamic endocrine 
output, and could provide a neuroanatomical explanation to various conditions, for 
instance side effects observed in patients under pharmacological treatments, such as 
antipsychotics, that target the D2 receptor. It also illustrates the caveats of delivering 
drugs at systemic level and thereby highlights the importance of direct targeting. These 
new insights could thus be the foundation of new D2 mediated therapeutic strategies for 
treating hormonal disorders and/or pituitary adenomas that give rise to e.g. 
hyperprolactinemia, hyperthyroidism (see Singh and Hershman, 2017) or acromegaly, 
but likely not for instance Cushing’s disease (see Störmann and Schopohl, 2018); a 
condition caused by dysregulations in corticotropin-releasing hormone expressing 
neurons or corticotrophs, where no D2 receptor could be identified (see study V). 
 
Figure 13. Schematic presentation of dopamine D2 receptor expression in parvocellular neurons of 
hypothalamus and endocrine cells of anterior pituitary. Cells that express D2 receptor have been 
marked with (Y), and cells that doesn’t express D2 receptor have been faded. See list for abbreviations. 
GHRH SST TRH DA GnRH CRH
Somatotrophs
Hypothalamus
Anterior Pituitary
ME
LactotrophsThyrotrophs Gonadotrophs Corticotrophs
?
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4.2.4 Involvement of D2 receptor in acromegaly 
Acromegaly is a hormonal disorder, caused by excessive growth hormone release during 
adulthood, which causes bones and body extremities to grow abnormally (see Melmed, 
2009). It is usually caused by pituitary adenomas and is treated with surgery, 
somatostatin analogs or D2 agonists (see Zahr and Fleseriu, 2018). By studying the 
dopamine receptors in the hypothalamus and the pituitary, we found D2 receptor 
expression in a subpopulation of somatostatin expressing neurons in the hypothalamus, 
but not in the somatotropic cells of the pituitary. 
Activation of D2 receptors in the hypothalamus would be predicted to impair the 
inhibitory effects of somatostatin on somatotrophs, and thus lead to increased growth 
hormone release, which makes our data, at an initial glance, difficult to reconcile with 
clinical observations. However, investigations of pituitary adenomas, have revealed 
expression of D2 receptors on somatotropinomas from acromegaly patients (Neto et al., 
2009), which would provide an explanation why patients respond to D2 agonist 
treatments. Notably, the literature also reports D2 receptor expression on normal 
somatotrophs (e.g. see Ben-Shlomo et al., 2017). This however, does not seem to be 
supported by the original data provided by Neto et al. (2009), which did not distinguish 
somatotrophs from the rest of the endocrine cells in the pituitary. 
It should be mentioned that bromocriptine treatments, in line with our results, does not 
always suppress growth hormone secretion in acromegaly patients, and the opposite 
where the treatment leads to increase secretion has also been reported (Arihara et al., 
2014). This illustrates why understanding of the entire system is necessary to be able to 
provide effective treatments for different patients. Finally, it should be noted that our 
data currently lack information about dopamine receptor involvement on GHRH 
expressing neurons which could have implications on the somatotrophic axis. 
4.2.5 D1 receptors are expressed in ependymal cells 
Possible D1 receptor expression was observed in a subpopulation of the ependymal cells 
of the third ventricle, lining the wall of the arcuate nucleus. This is a curious finding since 
previous records of these cells in the literature are absent. These results demand further 
investigation and confirmation. Considering the methodology in use, the signal could 
have three different explanations. The first explanation is that these cell do in fact 
express D1 receptors, which could be confirmed by in situ hybridization experiments. 
The second explanation is that observed signal is a transgenic artefact (see section 3.1.2). 
In such case, the strong expression of EGFP can, nevertheless, be used to target these 
highly underappreciated cells for further anatomical and electrophysiological 
interrogations.  
A third possibility is gap junction mediated EGFP translocation, from D1 receptor 
expressing neurons to the ependymal cells. As EGFP is too large to passively diffuse 
through a gap junction pore (see Alexander and Goldberg, 2003), this translocation 
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would utilize a different mechanism. Three different gap junction dependent 
mechanisms, have been described in the literature, which are through internalization 
(Jordan et al., 2001), cytoplasmic bridges (Bukauskas et al., 1992) or tunneling 
nanotubes (Wang et al., 2010). This would constitute a novel circuitry involving 
ependymal cells, and provide hypothalamic neurons access to larger proteins in the 
blood and the cerebrospinal fluid. 
4.3 CALCIUM BINDING PROTEINS IN THE ARCUATE NUCLEUS 
In the first study included in this thesis, the expression pattern and neurochemical 
identity of three calcium binding proteins, i.e. calbindin-D28k, calretinin and 
parvalbumin, in the arcuate nucleus have been investigated. Both mRNA and 
immunoreactivity were detected for calbindin-D28k and calretinin. Results from one 
parvalbumin antiserum was, however, ambiguous as it, contrary to in situ hybridization 
experiments and other parvalbumin antiserum, showed immunoreactivity in the 
arcuate nucleus. The exact reason for this discrepancy could not be elucidated from the 
study. It should be mentioned that the majority of the data from study I, together with 
data from other studies (Celio, 1990; Fortin and Parent, 1997), provide evidence against 
expression of parvalbumin in the arcuate nucleus of juvenile male rats. 
4.3.1 Possible antisera cross-reactivity 
As all three calcium binding proteins investigated in study I belong to the EF-hand 
family, and thereby exhibit similar motifs in their 3D structure, it is plausible that some 
(but not necessarily all) immunoglobulins in the polyclonal parvalbumin antisera fail to 
distinguish these structures in fixed tissues. Closer examination of multiplex 
immunostainings did show overlap between the two antisera targeting calbindin-D28k 
and parvalbumin to some extent. 
The co-expression is, however, not absolute, which is usually expected when antisera 
cross-react. By staining the two targets separately, cross-reactivity at the level of 
secondary antisera was ruled out. The fact that parvalbumin was targeted with a 
polyclonal antiserum could, however, provide an explanation. If only a subpopulation of 
the immunoglobulins cross-react, the antisera, that has been titrated to be used when 
all immunoglobulins are active, will be less potent and mainly detect areas with a high 
calbindin-D28k concentrations. This diminished signal was exactly what was observed 
in the experiments where antisera PV-25 was used. 
4.3.2 The functional role of calcium binding proteins in the arcuate 
Many calcium binding proteins, including calbindin-D28k and calretinin, have been 
identified to function in signal transduction, in addition to calcium buffering (compare 
section 1.3). To our best knowledge, parvalbumin, has so far not been identified to be 
involved in signal transduction, and is considered to be a “pure” calcium buffer. 
Although the functional role of these calcium binding proteins were not elucidated in 
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this study, it is interesting that the calcium binding protein that is known to only act as 
buffer, was absent. Future studies should investigate if the role of calcium binding 
proteins in the arcuate nucleus is limited or not to signal transduction. 
4.3.3 Calcium binding proteins are expressed in POMC neurons 
Of all the neuronal populations in the arcuate nucleus that were investigated, POMC 
neurons were the only ones that expressed calcium binding proteins. Interestingly, the 
expression was not uniform in the population, but both a rostro-caudal and a medial-
lateral differentiation could be observed. 
Diversity in arcuate POMC neurons has previously been identified in regards to 
projection patterns (Swanson and Kuypers, 1980; Baker and Herkenham, 1995; Elias et 
al., 1998, 1999), sensitivity to metabolic hormones (Williams et al., 2010) and amino 
acid transmitter phenotype (Collin et al., 2003; Meister, 2007; Hentges et al., 2009; 
Jarvie and Hentges, 2012; Wittmann et al., 2013). The data from all these studies 
together with current findings presented in study I can be summarized as follows: The 
rostral POMC neurons express calretinin, respond to insulin and project caudally to the 
autonomic areas. The caudal POMC neurons express calbindin-D28k, project within the 
hypothalamus and respond to leptin. It should be emphasized that the correlation of 
these data is not confirmed yet and remains to be determined in the future. 
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CHAPTER 5  
CONCLUDING REMARKS 
n the studies presented in this thesis, we have investigated the dopamine 
system in the hypothalamus with a particular focus on the TIDA neurons. We 
have identified an anatomical substrate for innervation by serotonin and 
hypocretin/orexin and showed that these modulators do alter the electrophysiological 
behavior of the cells. We have also provided a comprehensive map of D1 and D2 
expressing cells in the hypothalamus, the pituitary and some of the circumventricular 
organs. We identified cell populations that express either D1 or D2 receptors. Finally we 
provided evidence that both calbindin and calretinin are expressed in the arcuate 
nucleus, particularly in POMC neurons, which are subdivided into two groups based on 
the expression of these two calcium binding proteins.  
These data provide evidence to understand the underlying circuitries that enable the 
hypothalamus to work, in order to maintain homeostasis and drive motivated behaviors, 
which for instance can be used to explain physiological features in hormonal control, 
predict pharmaceutical agents’ actions and adverse effects. This understanding also 
provide a solid basis for future development of treatments in diverse areas of medicine. 
 
I 
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CHAPTER 8  
NEUROART 
cquiring all the micrographs that has been used as a basic foundation for the 
studies included in this thesis, required countless of hours in the dark room 
and in the basement, where I had to either look in the oculars to investigate 
the results, or stare at the computer screen to optimize acquisition settings. Had it not 
been for the beautiful world visualized in the microscope, the workload had not been 
endurable. As a way to share the marvelous world of neuroscience and fluorescence 
microscopy, and to raise interest in the general public, I used some of the data in a more 
artistic way in my Christmas greetings every year. 
Some of these greetings have been included in this sections. These Christmas cards are 
a manifestation to how fun science can be, but also demonstrate technical as well as my 
personal developments in the last decade, as the resolution of the micrographs I have 
acquired has throughout the years increased tremendously. 
 
 
 This was the very first NeuroCard I made. It is an immunofluorescence visualization of 
parvalbumin neurons (see study I), not in the hypothalamus, but in cortex. The underlying 
micrograph originates from the very first immunostaining I have done on brain sections.  
A 
2010 
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A cortical neuron identified by fluorescence microscopy, is shining up the sky and guiding 
the three wise men to baby Jesus. A neuron is the functional unit of the brain and the very 
basic building block that give rise to our rational and intelligence. This greeting was my way to proclaim that 
rational is the only path to transcendence, and that it is lighten up by science. 
 
 
The tree, the star and the decorations are all different kind of neurons from cortex as well as 
from hypothalamus, which has been visualized and used in real experiments. A fully 
decorated tree and a merry life is only possible, if they are all present, in the right place, and interconnected 
correctly.  
2011 
2012 
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The arborization of axon and dendrites of cortical neurons can be quite complex. To generate 
a full reconstruction of a complex neurons through manual tracing in Neurolucida (see 
section 3.7.2) can take a couple of days of work. Fortunately, the studies in this thesis focused on TIDA 
neurons, which are far less complex. Nonetheless, I have traced quite a few cortical neurons as well. The 
Christmas decoration on this greeting is a reflection of the amount of hard work that lays behind a merry 
celebration.  
 
 
Inspired by the Nobel prizes in Chemistry as well as Physiology or Medicine in 2014, the 
motives on the card originate from cortical neurons, dendrites and dendritic spines and are 
acquired with super resolution STED microscopy. The dendritic spines are pseudo colored.  
 
2013 
2014 
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Inspired by the vast number of in situ hybridization experiments I have done for the past 
years. The stars are actually experimental data, i.e. visualization of fluorescent mRNA of 
dopamine receptor D2 in the hypothalamus (see study V), magnified about 1000x. To better understand the 
role of dopamine in hypothalamus may aid us identify new therapeutic targets as well as understand the 
mechanism (and side effects) of existing therapeutic agents. 
 
 
Inspired by recent development in microscopy resolution and real research data, dendritic 
spines are lighting up the path to baby Jesus, sheltered under a neuron tree. The stars are 
also background staining from the brain, magnified more than a thousand times. Seemingly countless and 
insignificant in the sky, each dot in fact harbors an entire world. Our ability to investigate the brain in such 
detail enables us to better understand how individual physiological changes through life are in fact linked 
with changes in our brains. 
2016 
2017 

